National Cancer Institute (NIH), USA

2014

  • (pdq5)integrated genetic and epigenetic prognostication for acute myeloid leukemi
  • (pq #4) single cell barcoding for studies of study clonal evolution in glioblasto
  • (pqa 2) obesity & obstructive sleep apnea in hepatocellular carcinoma progression
  • (pqa1) the antipsychotic thioridazine protects against medulloblastoma (mb): volu
  • (pqa2) impact of obesity on endogenous mutational hotspots
  • (pqa-4) organoid omics to detect and defeat ductal pancreatic cancer
  • (pqb-2) “driver” vs. “passenger” epigenetic events in ewing sarcoma
  • (pqb2) ontogeny of the tumor-immune interplay in a developmental malignancy
  • (pqb3) cd4 t cell response to bcr-abl-positive leukemia
  • (pqb-3) driver gene-induced inflammation in pancreatic cancer development
  • (pqb5) epigenetic drivers of hematopoietic stem cell transformation
  • (pqb5) reconstruction of evolutionary networks using cross-sectional genomic data
  • (pqb5)molecular wiring and therapeutic targeting of egfr and pdgfr signaling netw
  • (pqc2) optical hallmarks of aggressive clones within oral field cancerization
  • (pqc5) mri of magnetically labeled immune/stem cells for early tumor detection
  • (pqc5)early detection pancreatic cancer by hyperpolarized silicon nanoparticles
  • (pqd1) lmpact of cytotoxic and targeted therapy on clonal evolution of cll
  • (pqd2) molecular basis for the chemosensitivity of testicular germ cell cancers
  • (pqd2)new biomarkers and pathways to enhance cure in ovarian cancers
  • (pqd3) mechanisms of prolonged initial disease-free survival in glioblastoma
  • (pqd3)molecular profiles associated with long-term survival in pancreas cancer
  • (pqd4) microrna dysregulation in field effect is a prerequisite for tumorigenesis
  • (pqd5) a novel genetic strategy to predict efficacy of anti-cd20 antibodies
  • (pqd5) avatar-directed treatment for ovarian cancer
  • (pqd-5) patient derived orthotopic xenograft models for drug response prediction
  • (pqd5)biomaterials-based adaptive tumor microenvironments for in vitro drug scree
  • 3d-microtumor_gbm xenoline proband modeling of kinome-directed therapy
  • 99mtc-tilmanocept for sentinel lymph node biopsy in cervical cancer surgeries
  • A genetically defined system to identify factors essential for kras oncogenesis
  • A longitudinal assessment of frailty in young adult survivors of childhood cancer
  • A molecular mechanism whereby metformin protects against liver cancer
  • A mouse model of dnmt3a-associated hematologic malignancy
  • A new treatment paradigm for alk-driven cancers exploiting oncogene overdose
  • A novel agent with dual functions to treat head and neck cancer
  • A novel antibody drug conjugate for metastatic renal cancer treatment
  • A novel approach to treating glioblastoma through activation of the liver x recep
  • A novel epigenetic circuit in acute leukemia
  • A novel functional genomic pipeline for target identification in sarcoma
  • A novel mediator of obesity associated hepatocellular carcinoma (hcc)
  • A novel multimodality immune based platform in advanced mycosis fungoides
  • A novel oncogenic role for cdc20 implications in adult t cell leukemia treatment
  • A novel regimen to target both pancreatic cancer k-ras and antiapoptotic proteins
  • A novel role for pml bodies in leukemic transformation
  • A novel soluble receptor-based therapy for kidney cancer
  • A novel targeted delivery system for cancer treatment and diagnosis
  • A novel targeted therapy for hnscc based on a novel activity of cetuximab
  • A phase i study of ced of liposomal-irinotecan using imaging in high grade glioma
  • A phase i trial combining iv fenretinide and iv safingol to target overproduction
  • A protein based strategy to reverse bone marrow failure resulting from radiation
  • A radiotherapeutic for breast cancer brain metastases
  • A role for notch in self renewal in embryonal rhabdomyosarcoma
  • A small molecule broad spectrum inhibitor of antiapoptotic genes to treat cancer
  • A zebrafish model to study the role of the microbiota in the etiology of intestin
  • Actin dynamics as a therapeutic target for bcr-abl-positive acute lymphoblastic leukemia.
  • Active viral hepatitis diagnostics to support prevention/treatment of hcc
  • Adaptable hydrogel platform to study pancreatic cancer
  • Advanced training in urologic oncology
  • Alk rearrangements in aggressive thyroid cancer
  • Altered microrna as a biomarker for the onset of obesity related womens cancers
  • Alternative end-joining in dna repair and chromosomal translocations
  • An early-phase clinical trial evaluating abc294640 in patients with refractory/re
  • An epigenetic strategy for restoring carboplatin sensitivity in ovarian cancer
  • An inhibitor of multiple anti-apoptotic gene products for pancreatic cancer
  • An innovative in situ cell reprogramming technology for cancer treatment
  • Analysis of intratumoral crosstalk in clonal populations of ovariantumor cells
  • Application of boolean networks to discover stem and progenitor cells
  • Arid5b and disparities of childhood leukemia
  • Aspirin and cancer prevention in lynch syndrome: from cell to population data
  • Assessment of hypercoagulability in cancer patients using sonorheometry
  • Assessment of microvessel density and tumor proximity for prognosis of cancer
  • Autoimmune conditions, genetic variations, and lymphoma etiology
  • Autophagy as a microenvironmental regulator of tumorigenesis and resistance
  • Autoregister: a system for enhancing the accuracy of tumor change detection
  • B cell repertoire molecular platform for antibody drug discovery
  • Bayesian approaches for missingness and causality in cancer and behavior studies
  • Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas
  • Biosensor assay to screen for signaling pathway inhibition in cancer
  • Blood-based angiome profiling to direct bevacizumab therapy in ovarian cancer
  • Bridging the gap from discovery to survival in the interlymph consortium
  • Building upon a tradition of excellence. The nctn at indiana university
  • Cathepsin inhibitors for treatment of breast cancer induced bone pain
  • Cd4 t cell response to bcr-abl positive leukemia
  • Cell cycle reprogramming for therapeutic targeting of btk in lymphoma
  • Cell line panel profiling for discovery of multiple myeloma therapeutics
  • Cellular and biologic origins of cll
  • Central neck dissection in patients with clinical node negative thyroid cancer
  • Cert imaging of cancer
  • Characterization of a non-canonical role for foxo1 in b cell lymphoma
  • Characterization of drug survival by pancreatic cancer cells in vitro and in vivo
  • Characterization of epigenetic targets in prostate cancer
  • Characterization of non-competitive proteasome binding
  • Characterizing the genomic architecture and molecular mechanisms driving the form
  • Chemical modulation of chromatin signaling in lymphoid malignancies
  • Chemical optimization of a novel class of usp7 inhibitor for cancer treatment
  • Chemically programmed bispecific antibodies for cancer therapy
  • Chemofilter: a novel catheter device to enable high-dose chemotherapy treatment
  • Chemoprevention through chromatin modulation in barrett’s esophagus
  • Children’s oncology group statistics and data center
  • Chimeric antigen receptor modified t cell therapy for pancreatic cancer
  • Chronic stress in the absence of blm induces metabolic alterations
  • Clinical development of cancer-specific mrs biomarkers in malignant gliomas
  • Cll mutation detection and monitoring from blood using ac electrokinetics
  • Clustered semi-competing risks analysis in quality of end-of-life care studies
  • C-myc dependent regulation of de novo lipogenesis in b-cell lymphomagenesis
  • Cog nctn network group operations center
  • Cog nctn solid malignancy integrated translational science center
  • Cognitive change after proton rt vs. Photon or surgery for pediatric brain tumor
  • Collaborative human tissue network (chtn)
  • Combinatorial nanotechnology-based regimens for pancreatic cancer chemoprevention
  • Communication outcomes after head & neck cancer
  • Comprehensive approach to improve medicine adherence in pediatric leukemia
  • Conferring in vivo metabolic resistance to a highly selective anti-aml agent
  • Contract title: sbir phase i topic 324 development of an imaging agent targeting
  • Contractor: mayo clinic; dunns: 006471700; pilot study of egfr inhibition with erlotinib in cirrhosis to inhibit firbrogenesis and prevent hepatocellular carcinoma hhsn261201200042i; task order hhsn26
  • Control of breast cancer metastasis by epstein-barr virus microrna
  • Control of the apoptosome in epithelial ovarian cancer to enhance chemotherapy
  • Convergence of creb and myc pathways in oncogenesis.
  • Cooperating pathways in gliomagenesis
  • Correcting aberrant splicing of the human cd22 gene
  • Crucial microenvironmental cofactors for pancreatic cancer pathogenesis
  • Curated copy number variation tcga database and analytical platform for use in ca
  • Cytotoxicity of mln4924 in acute myeloid leukemia
  • Deep sequencing for minimal residual disease detection in acute lymphoblastic leu
  • Defining microrna signatures for early detection in brca-mutated ovarian cancer
  • Defining novel drivers and predictive signatures of metastasis in osteosarcoma th
  • Defining the role and mechanism of pak1 in supporting pancreatic cancer
  • Defining the temporal sequence of pi3k pathway mutations in bladder cancer
  • Defining the tn-glycoproteome of in situ colorectal tumors and mechanisms of tn e
  • Deimmunized tlr5 agonist for anticancer therapy
  • Descriptionpatterns of care/quality of care study: diagnosis year 2013 (seer)period of performance: 08/15/2014-08/14/2015line item #: 1
  • Design and development of a small molecule-controlled activator of ras
  • Detection of cox-2-expressing bladder cancer by fluorocoxib a
  • Determination of musashi1/cd44v6 signaling in mesenchymal glioma stem cells
  • Determining the kinetics and mechanism of pancreatic tumor regression following genetic deletion of pi3k p110a
  • Determining the role of cux1 in myeloid neoplasia
  • Determining the role of dnmt-interacting rnas in myeloid disorders
  • Developing an anti-sialyl-lewisa diabody for immunopet imaging of pancreas cancer
  • Developing crm1 inhibitors in aml
  • Developing nanotechnology to target hmga1 in pancreatic cancer
  • Developing novel stat5 protein inhibitors for treatment of leukemias
  • Developing therapeutics that target rad51 to treat leukemia and lymphoma
  • Development and application of selective covalent cdk7 inhibitors
  • Development of a coiled-coil therapeutic for non-hodgkin’s lymphoma
  • Development of a small molecule inhibitor for kshv lana
  • Development of advanced c-arm cone-beam ct for the treatment of liver cancer
  • Development of gli1-selective therapeutics for hedgehog pathway-dependent cancers
  • Development of integrated analysis methods and applications to tcga data
  • Development of transporter targeted platinum drugs for pediatric tumor
  • Diagnostic assays for ovca recurrence using paraneoplastic antigens and epitopes
  • Directional motility and erm scaffolding in pathfinder pancreatic carcinoma cells
  • Discovering genomic rearrangements under selection in serious ovarian cancer
  • Discovery of constrained peptoid oligomers for novel therapy of multiple myeloma
  • Discovery of homologous recombination dna repair deficiency in lung tumor
  • Discovery of risk loci and genomics of pancreatic cancer through exome sequencing
  • Disrupting brain metastogenesis in breast cancer
  • Dissecting the genetics of follicular lymphoma to find new therapies
  • Dissecting the role of stat3 and targeting ovarian cancer
  • Dissecting the roles of tsc1 and tsc2 at the centrosome
  • Distribution, regulation and function of a novel lysine ptm in metabolic disease
  • Drosophila models of ret fusions in papillary thyroid carcinoma
  • Dual targeted nanoparticle therapy for glioblastoma multiforme
  • Dynamical models of cetuximab resistance in hnscc based on serial genomics data
  • Early detection of pancreatic cancer in diabetics
  • Ecog-acrin integrated leukemia translational research center
  • Effects of uv irradiation on dna structure-induced genetic instability
  • Elucidate the role of mir-141 in brain metastasis from breast cancer
  • Elucidating and targeting epigenetic oncogenic networks in pancreatic cancer
  • Elucidating the role and regulation of epithelial plasticity in metastasis
  • Embryonal brain tumor networks
  • Enable early and sensitive in vivo detection of liver metastasis by protein-based
  • Endothelial cell activation regulates aml growth and relapse
  • Engineering a supramolecular platinum nanoparticle for pediatric cancer
  • Engineering alpha fetoprotein and glypican-3 to develop hepatoma (hcc) vaccines
  • Engineering organelle function to rewire cancer cell metabolism
  • Enhancing glioma-specific immunity
  • Enhancing oncolytic virus function with type iii interferon
  • Epigenetic modulation of lung cancer metastasis by a novel long intergenic rna
  • Epigenetic priming in pancreatic cancer chemotherapy
  • Epigenetic regulation of pancreatic cancer
  • Epigenetic regulation of t-cell dysfunction in chronic lymphocytic leukemia
  • Epigenetics and risk factors for breast and ovarian cancer in high risk women
  • Epo increases macrophage suppression
  • Erk inhibitor resistance and erk isoform-dependent growth in pancreatic cancer
  • Evaluating notch signaling as a therapeutic target in ovarian cancer
  • Evaluation of impact of anti-vegf drugs on concomitant chemotherapy in gbm
  • Evaluation of positron emission tomography-magnetic resonance imaging (pet-mri)
  • Ex vivo purging strategy for treatment of multiple myeloma
  • Exercise and quality diet after leukemia
  • Exosomal microrna as a driver of immune evasion in aml
  • Exploiting metabloic defects in tumors with mutant idh1 and idh2
  • Exploring a new therapeutic approach through targeting epigenetic enzymes in all
  • Exploring the role of mediator in oncogenic transcription
  • Expression system and process development for mis scale up
  • F10: a novel therapeutic to treat refractory or relapsed aml
  • Failed tubulin inhibitor reformulated as localized adjuvant therapy for head and neck cancerpop: 09/12/2014-06/11/2015
  • Fatty acid transporters in cholangiocarcinoma pathogenesis
  • Fiber scanning stimulated raman scattering (srs) endoscope
  • Fingerprinting invasive membrane protrusions to discover metastatic signatures
  • Fluorescence lifetime imaging/spectroscopy system for robotic cancer surgery guid
  • Fluorescence lifetime technique for detection of radiation necrosis vs gliom
  • Foxm1 in liver cancer.
  • Frostbite – a unique catheter for endoscopic cryoablation
  • Fullerene-based radioprotectors for use during brain radiotherapy, period of performance 09/15/2014 – 05/15/2015
  • Function of the pr domain of the mdsi-evi1 in mll fusion protein leukemogenesis
  • Function on non-coding rna, malat1, in b-cell development and lymphoma
  • Functional analysis of brca1 in dna damage response and tumor suppression
  • Functional analysis of lncrnas in epithelial ovarian cancer
  • Functional and biologic significance of deacetylase3 inhibition in myeloma
  • Functional significance of cd133 in pancreatic cancer
  • Functional significance of pre-leukemic hsc in human acute myeloid leukemia
  • Genetic dissection of acute myeloid leukemia.
  • Genetic modifiers for cancer stem cells in secondary mds/aml
  • Genomic instability from loss of xpg, a brca1/2 partner: role in ovarian cancer?
  • Genomic profiling and development of murine models of transformation of mpns
  • Germline susceptibility in double primary cancers via nexy-generation sequencing
  • Global assessment of myeloma response to chemotherapy
  • Glycocalyx and ncor2-notch-mediated stemness in glioblastoma aggressiveness
  • Gpcr signaling in scchn: integration with egfr
  • Gpcrs: novel targets in cancer-associated fibroblasts
  • Gsk3 inhibition as an adjuvant therapy for burkitt’s lymphoma
  • H3k9 methylation and pancreatic cancer chemoresistance
  • Harnessing the multipotency of cancer stem cells for differentiation therapy
  • Hdac8 mediated regulation of acute myeloid leukemia pathogenesis and maintenance
  • Healthy kids after cancer: a physical activity and nutrition intervention
  • Hedgehog acyltransferase as a target in cancer
  • Hhsn2612012000131/hhsn26100010base contract title: preclinical efficacy and intermediate endpoint biomarkers. Task order title: preclinical studies to evaluate the combination of metformin and as
  • Hhsn2612012000151/hhsn2610006base contract title: preclinical efficacy and intermediate biomarkers. Task order title: modulation of mirna expression in blood or other biological fluids compared wi
  • Hhsn2612012000201/hhsn26100006 title: preclinical in vitro and in vivo screening assays for cancer preventative reagent development, project: targeting cck2r for pancreatic cancer prevention
  • High dose radiation therapy to direct immune responses to pancreatic cancer
  • High resolution helicobacter snp typing to identify carcinogenic cagpai variants
  • Highly specific and efficient vectors for targeting pancreatic cancer
  • High-resolution analysis of chromatin regulation by the max network
  • Hormonal effects on fallopian tube and ovary inclusion cysts, and ovarian cancer
  • Human-enzyme mediated, systemic depletion of cystine for cancer treatment.
  • Identify otx2-interacting proteins repressing differentiation in medulloblastoma
  • Identifying biomarkers of cisplatin resistance mechanisms in ovarian cancer
  • Identifying signaling and anti-apoptotic dependencies in acute myeloid leukemia
  • Identifying stat3 co-dependencies in cancer
  • Igf maternal folic acid supplementation and leukemia risk in children: a pooling of prospective data in the international childhood cancer cohort consortium (i4c)
  • Igf::ot::igf – ind enabling development of nanogmp: targeted
  • Igf::ot::igf sbir phase i topic 331: biopsy guidance with coherent raman spectroscopy
  • Imaginab
  • Imaging guided surgery using fluorescently labeled cetuximab
  • Imaging idh1 mutations in glioma and other malignancies
  • Immune-based brain cancer diagnostic for rapid, accurate disease classification
  • Immunity to mhc-restricted phosphopeptides in healthy donors and cancer patients
  • Impact of low il-10 levels at birth and leukemia risk
  • Impact of malaria on shaping immunity to ebv in the etiology of burkitt lymphoma
  • Impact of primary tumor development stage on prognosis and outcome in b-all
  • Impact of short inverted repeats on genetic instability at mutation hotspots
  • Improved response assessment in anti-angiogenic treatment of glioblastoma
  • Improving cpt-11 efficacy using structural and chemical biology
  • Improving extent of glioblastoma resection by combining volumetric mrsi and 5-ala
  • Improving self-management in head and neck cancer
  • In vivo study of of chemokine antagonists for cancer
  • Individualized peptide monitoring for plasma cell dyscrasias by proteomics
  • Inflammation, autoimmunity and ovarian cancer
  • Inflammatory basis of depression in ovarian cancer
  • Inhibiting stat1 as a novel graft-versus-host/graft-versus-leukemia therapy
  • Inhibition of pge2 for mobilization of autologous peripheral blood stem cells
  • Instructive cues in glioblastoma hierarchies
  • Intact protien as a cancer fuel source
  • Integrated microfluidic exosome profiling for early detection of cancer
  • Integrated models for metastatic phenotype and outcome prediction in osteosarcoma
  • Integrated translational genoproteomics center at washington university
  • Integrating mass cytometric and transcriptomic profiles of solid tumors
  • Integration of glycolysis with the epithelial-mesenchymal transition
  • Integrative modeling of gene expression into gwas of glioma
  • Integrin avb3 targeted nanoparticles as a novel therapy of bone metastases
  • Interactive omics: black raspberry metabolites and the oral microbiome in smokers
  • Interferon activated necroptosis as a new therapeutic avenue for kidney cancer
  • Intervention of ras-erk-activated cancers
  • Intraoperative confocal microscopy for quantitative delineation of low-grade glio
  • Investigating and targeting tams in the glioma microenvironment
  • Investigating branched chain amino acid metabolism in pancreatic cancer
  • Investigating lgr5/wnt signaling in ewing sarcoma pathogenesis
  • Investigating resistance to flt3 inhibitors in aml
  • Investigating the association between the somatic and inherited genetics of pheoc
  • Investigating the cause of racial/ethnic disparity in hepatocellular cancer risk
  • Investigating the function of mtbp in lymphoma
  • Investigating the roles of lncrnas in cancer and development
  • Investigating wnt and lgr5 signaling as regulators of lung cancer heterogeneity
  • Investigation of therapeutic modulators of apoptotic priming in pancreatic cancer
  • Investigation of tumor suppressive mir-148a in idh mutant gliomas
  • Investigations of cryab activity in gliomagenesis
  • Ire1/xbp1s signaling: a novel essential regulator for bone marrow microenvironmen
  • Iron addiction and the biology of ovarian cancer
  • Itsc for leukemia: novel molecular strategies for nctn: “individualized” therapie
  • Kaposi’s sarcoma-associated herpesvirus mimics of cellular micrornas
  • Kir-favorable haploidentical transplantation in children
  • Kshv interactions with host inflammasome components
  • Large scale synthesis and biodistribution of expansile nanoparticles
  • Large-scale characterization of anti-cancer antibody responses in lung adenocarci
  • Leukotriene-induced nestin expression promotes medulloblastoma tumorigenesis
  • Long non-coding rnas in pancreatic cancer
  • Low-cost enabling technology for image-guided photodynamic therapy (pdt) of oral
  • Lynch syndrome screening network (lssn) database
  • Malt1 targeted therapy for b-cell lymphoma
  • Manipulation of kinase signaling by the human oncovirus kshv
  • Maternal comorbidities, prescription drug use in pregnancy and childhood cancer
  • Mdct quantification of hepatic tumor viability for assessment of cancer therapy
  • Mechanism of notch-induced leukemogenesis in lymphocytes
  • Mechanisms and targeting of swi/snf alterations in pancreatic cancer
  • Mechanisms governing tumor differentiation and metastasis
  • Mechanisms of pak1 activation, signaling and tumor resistance
  • Mechanisms of resistance to ponatinib therapy in chronic myeloid leukemia
  • Mechanisms of tumor suppression by epigenetic regulators in pancreatic cancer
  • Mechanisms of twist1-induced sorafenib resistance in liver ca
  • Menin-mediated epigenetic tumor suppression
  • Merkel cell polyomavirus t antigens and cancer
  • Metabolic regulation of cellular junction proteins
  • Metabolic reprogramming in liver cancer cells by a novel tumor suppressor
  • Metabolic therapy of gbm guided by mrs of hyperpolarized 13c-pyruvate
  • Methylthioadenosine phosphorylase and adomet synthetase in cancer
  • Micellar daunorubicin for the treatment of bone cancer
  • Microfluidic approach for the development of a three-dimensional bone marrow micr
  • Microfluidic device to profile chemosensitivity in glioma slice cultures
  • Microrna-125b physiologically and pathologically regulates myelopoiesis through i
  • Microrna128 regulation of polycomb repressor complexes1 and 2 in glioblastoma
  • Microrna-1291 in regulation of xenobiotic disposition and cell differentiation
  • Micro-western array methodology for assessment of preanalytical variability in bi
  • Mode of action of the amaryllidaceae alkaloid lycorine-promising anticancer agent
  • Modeling p53 mutant-associated cancer with lfs patient-derived ipscs
  • Modeling transformation: myeloproliferative neoplasms to acute myeloid leukemia
  • Molecular analysis of physical microenvironmental control of tumor cell invasion
  • Molecular and cellular communications in liver tumorigenesis
  • Molecular basis for the impact of sex on brain tumorigenesis
  • Molecular characterization of myeloma and related asymptomatic precursor states
  • Molecular determinants of prognosis in limited-stage follicular lymphoma
  • Molecular diagnostics for risk stratification and monitoring of neuroblastoma
  • Molecular etiology of cervicovaginal adenosis by in utero hormone exposure
  • Molecular evaluation of targeted therapies in lymphoid malignancies
  • Molecular genetics of liver cancers
  • Molecular insights into the fanconi anemia tumor suppressor signaling pathway
  • Molecular mechanism of bitter melon juice efficacy against pancreatic cancer.
  • Molecular mechanism of osteoblastic inhibition in myeloid malignancies
  • Molecular targets of translocation t(4;14) in multiple myeloma pathogenesis
  • Molecularly targeted therapy for lymphoma
  • Monobody therapy for gynecologic cancers
  • Mr guided focused ultrasound controlled stem cell therapy for brain tumor
  • Mri fluorescence tomography for quantifying tumor receptor concentration in vivo
  • Mtdh regulates fanconi anemia repair pathway to mediate drug resistance
  • Mucins in the diagnosis and prognosis of pancreatic diseases
  • Multi-center thyroid tumor and cancer registry
  • Multiplexed in vivo drug screening: inhibitors of metastatic seeding
  • Multiplexed kinase biosensor technology to detect leukemia signaling with mass sp
  • Multiplexed ovarian cancer microfluidic tissue microarray
  • Multi-tracer pet/ct imaging of gemcitabine response in pancreatic cancer
  • Nano-particles eradicating leukemia stem cells
  • Natural history of barrett’s esophagus using capsule endomicroscopy
  • Nci nctn- network lead academic participating site: usc
  • Nctn deep south research consortium
  • Needle biopsy preservation and preparation for rapid 3d pathology of pancreas
  • Network lead academic participating site grant from the roswell cancer inst.
  • Neuroplasticity-based cognitive remediation for pediatric brain tumor survivors
  • New aminothiol prevention of x-ray-induced mouse mutagenesis and tumorigenesis
  • New cancer therapeutic target
  • Non-catalytic functions of dna-pk in dna repair and tumorigenesis
  • Noninvasive measurement of oncogenic signaling pathways with 89zr-transferrin
  • No-nonsense approach to treat myeloid malignancies with asxl1 nonsense mutations
  • Non-peptide proteasome inhibitors as a novel anticancer agent
  • Novel activatable fluorophores for multicolor fluorescence-guided cancer surgery
  • Novel allosteric kinase inhibitors target imatinib-resistant gist
  • Novel and selective ampk activator for the treatment of hepatocellular carcinoma
  • Novel anthraquinones induce apoptosis by disruption mdm2/mdm4 interactions
  • Novel cell delivery method for brain tumor therapy
  • Novel dgkalpha inhibitors and immunotherapy for gbm and melanoma brain metastasis
  • Novel erbeta agonists for the treatment of gliomas
  • Novel experimental therapeutics for pancreatic cancer
  • Novel focal adhesion kinase autophosphorylation inhibitors against pancreatic cancer
  • Novel functions of pyruvate kinase m2 in dna double-strand break repair
  • Novel immunotherapy for brain cancer
  • Novel mechanisms of oncogenic transformation in lung cancer
  • Novel role for shed syndecan 1 in promoting an aggressive tumor phenotype
  • Novel role of samhd1 as a tumor suppressor in cutaneous t-cell lymphomas
  • Novel scfv-antibody fusion sirna carrier protein for macroglobulinemia treatment
  • Novel small molecule mdm2 inhibitors for pancreatic cancer therapy
  • Novel small molecule therapeutics for pancreatic cancer
  • Novel theranostics for pancreatic cancer
  • Novel topical radioprotector for gl mucosal exposure
  • Nrg oncology network group operations center
  • Nucleoside transporter-connexin interplay in pancreatic cancer chemotherapy
  • Oct to distinguish b/t tumor & non-tumor tissue in infiltrating brain cancer
  • Optimization of bifunctional pharmacophores for the treatment of neuroblastoma.
  • Optimizing radiosensitization in anaplastic thyroid cancer with metabolic imaging
  • Oral microbiome in esophageal adenocarcinoma
  • Organ preservation in rectal adenocarcinoma
  • Osu as network lead academic participating site for the nci nctn
  • Ovarian cancer gene therapy using hpv pseudovirion
  • Ovarian cancer therapy using cd40 ligand (cd40l)
  • Ovarian cancer using novel nanoparticle formulations
  • P130 and pim-1 as prognostic biomarkers and therapeutic targets in lung cancer
  • P90rsk2-stathmin signaling in metastatic human cancers
  • Pancreatic cancer cell mechanics and imaging
  • Pancreatic cancer vulnerabilities downstream of cooperating oncogenic mutations
  • Pancreatic cystic lesions: descriptive epidemiology and natural history
  • Pancreatic ductal adenocarcinoma is a disease of constitutive autophagy
  • Pancreatic-cancer imageable patient-derived orthotopic xenografts (ipdox)
  • Pathogenesis of malignant mesothelioma by the human polycomb complex bap1-asxl
  • Pathogenetic and prognostic studies for improved therapy of merkel cell carcinoma
  • Pathogenetic mechanism and clinical targeting of csf3r-driven cancer
  • Pathogenic mechanisms of csf3r mutations in leukemia
  • Pathophysiology of chemotherapy-induced cognitive deficits in juvenile rats
  • Patterns of care/quality of care study: diagnosis year 2013 (seer) period of performance: 08/15/2014 – 08/14/2015
  • Patterns of care/quality of care study: diagnosis year 2013 (seer)period of performance: 08/15/2014-08/14/2015line item #: 1
  • Patterns of care/quality of care study: diagnosis year 2013 (seer)period of performance: 08/15/2014-08/14/2015
  • Patterns of care/quality of care study: diagnosis year 2013 seer) hhsn261201300017i – university of utah; pop 08/15/2014 – 08/14/2015 to# hhsn261200004
  • Patterns of care/quality of care study: diagnosis year 2013seer) hhsn261201300015i – emory university pop 08/15/2014 -08/14/2015, to# hhns261200005
  • Patterns of care/quality of care: diagnosis year 2013 (seer)pop 08/15/2014 – 08/14/2015line item#: 1
  • Pd2/paf1 and pancreatic cancer stem cells
  • Peptide reporters for estimation of bcr-abl kinase activity in all patient cells
  • Peptide-mediated delivery of sirna for treatment of ovarian cancer
  • Perinatal hormonal biomarkers and risk of testicular germ cell tumors
  • Perinatal immune development and risk of childhood acute lymphoblastic leukemia
  • Perioperative stromal depletion strategies in pancreatic ductal adenocarcinoma
  • Pet imaging-guided personalized therapy in pancreatic cancer
  • Pet/mr study of metastatic lymph nodes in head and neck cancer
  • Phase i vaccine study using brain tumor initiating cells in who grade ii gliomas
  • Phenotypic plasticity associated with inhibition of hsp90
  • Phosphoinositol-3-kinase signaling and pik3ca: critical mitogenic drivers in head
  • Phosphorylated form of activated ikkbeta and pancreatic cancer
  • Pi3k pathway inhibition for philadelphia-like acute lymphoblastic leukemia
  • Plasma and serum biomarkers for hodgkin lymphoma
  • Pluripotent stem cells as a novel model to test hereditary cancer variants
  • Posterior cerebellar resection and pain processing in the pediatric brain
  • Potential therapeutic implications of targeting mir-150 in acute myeloid leukemia
  • Pqd2 rational combination of standard agents and immunotherapy to treat myeloma
  • Preclinical evaluation of a targeted bmi1 inhibitor in pancreatic cancer
  • Predicting hcc through glycomics
  • Prediction of treatment-related mortality and therapeutic resistance in aml
  • Predictive mri metrics for tumor aggressiveness in micropapillary thyroid cancer
  • Pre-leukemic hematopoietic stem cells and clonal evolution in human aml
  • Prevention of bone loss after pediatric hematopoietic cell transplantation
  • Professional development and late career transitions in pediatric hematology/onco
  • Prognostic metabolic signatures of cancers through mass spectrometry imaging
  • Prognostic potential of low-level mutations in meylodysplastic syndrome
  • Prohibitin 1 in liver injury and cancer
  • Prospective study of human oral microbiome and pancreatic cancer risk
  • Protein-coding and non-coding rna biomarkers for early detection of cll
  • Puerto rico nci community oncology research program minority/underserved
  • Quantitative (perfusion and diffusion) mri biomarkers to measure glioma response
  • Quantitative analysis of gbm invasion mechanisms with new imaging protocol
  • Quantitative mri models of hn cancers for physiological adaption of rt
  • Quantitative mrsi for the prediction of response to chemoradiation therapy in gbm
  • Radiation and receptor targeted radiotheranostic nanoparticles for glioblastoma
  • Radiolabeled trastuzumab to improve diagnosis and staging of her2+ gastric cancer
  • Reactivation of p53 and apoptosis in patient derived aml cells with cytoplasmic s
  • Reactive oxygen species-induced cxcl8 in ovarian cancer
  • Refining ovarian cancer subtype classifiers to incorporate biologic features
  • Regulation of cell migration by septin 2 in renal cancer
  • Regulation of lung cancer metastasis by zeb1
  • Regulation of redd1 and caspase-2 by fasn inhibition in ovarian cancer
  • Regulation of transcription and tumor suppression by mtg family members
  • Replicating tumor ecm in microchannels for 3d phenotypic hts assays
  • Reprogramming the metastatic microenvironment of pancreatic cancer through csf1r
  • Research career advancement: role of the sirt1 deacetylase in maintenance of flt3
  • Risk of hematologic cancers from repeated low-dose diagnostic radiation
  • Role of acetyl-coa in linking cancer cell metabolism and epigenetics
  • Role of age in liver cancer
  • Role of asxl1 in normal hematopoiesis and pathogenesis of myeloid malignancies
  • Role of autophagy in normal and transformed hematopoietic stem cells
  • Role of beta-catenin in apoptosis resistance of hepatocellular carcinoma
  • Role of epigenetic regulators in pancreatic cancer
  • Role of erbb receptor signaling in regulating normal and leukemic stem cell fate
  • Role of fog2/gata3 complex in lung cancer metastasis
  • Role of inflammation in cancer progression
  • Role of mef2b mutations in lymphomagenesis
  • Role of micrornas in the regulation of cml stem cell self renewal and survival
  • Role of mll1 and mll1 leukemogenic fusions in maintaining transcriptional memory
  • Role of multiple myeloma cancer stem cells in clinical disease
  • Role of p21 activated kinase in leukemogenesis
  • Role of tumor-associated endothelial cells in chaperoning tumor cells
  • Sbir phase ii topic “scalable automated brain tumor segmentation”
  • Screening for inhibitors of the cbx chromodomain
  • Second generation mti-101 analogs using a novel peptoid-peptide hybrid beta-hairp
  • Selective transduction of radioprotector protein, tousled, for treatment of cance
  • Sensitize leukemia cells to differentiation by inhibiting necroptosis signal
  • Sequence-based pathogen discovery in post-stem cell transplantation syndromes
  • Shanghai womens health study
  • Signal integration of transcriptional pathways in gliomagenesis
  • Signaling and targeting of 6-phosphogluconate dehydrogenase in human cancers
  • Sirt2 directs kras ir cell resistance and tumorigenesis
  • Smart targeting nano-doxorubicin against breast cancer
  • Smo inhibitor resistance in shh-subtype medulloblastoma: mechanisms and treatment
  • Sox9 signaling in lung adenocarcinoma
  • Specificity of the ubiquitin system in lymphoid malignancies
  • Stanford university nctn- network lead academic site
  • Stellate cells and their progenitor precursors in pancreas cancer progression
  • Stem cell gene therapy following r-epoch for non-hodgkin lymphoma in aids patient
  • Stem cell phenotype, glut3 expression, and metabolic stress resistance in gliobla
  • Steroid hormones regulate ovarian cancer progression and metastasis
  • Sting-activating gm-csf secreting allogeneic pancreas tumor cell vaccine therapy
  • Stopping tyrosine kinase inhibitors in cml patients (stop-tkis)
  • Stress response networks in cancer: systematic mapping and therapeutic potential
  • Stroma-mediated clonal evolution in multiple myeloma
  • Studying metabolic stress signaling in renal cancer
  • Survival mechanisms in leukemic nk cells
  • Synergy between mag-1 and cyclophosphamide for treatment of recurrent sclc
  • Synthesis and evaluation of novel kinase inhibitors as anti-metastasis agents for
  • Targeted chemoprevention of gastric carcinogenesis in high risk populations
  • Targeted delivery of theranostic nanoparticles carrying immune modulators
  • Targeted erythrocyte membrane-coated nanoparticles for the treatment of aml
  • Targeted therapies in cns lymphomas
  • Targeting acetyl-coa metabolism for the discovery of new anti-cancer therapeutics
  • Targeting aerobic glycolysis in t-all
  • Targeting bet bromodomain in pancreatic cancer
  • Targeting cancer stem cell initiation during pancreatic cancer development
  • Targeting casein kinase 1d/e (ck1d/1e) in cancer therapeutics
  • Targeting ccr2 to overcome immunosuppression and improve immunotherapy
  • Targeting cell surface grp78 as a novel therapy for pancreatic cancer
  • Targeting chromatin modifications in leukemia with trisomy 21
  • Targeting chronic lymphocytic leukemia with dna nanoparticles
  • Targeting determinants of ovca metastases in engineered 3d microfluidic platforms
  • Targeting diacylglycerol kinases in glioblastoma
  • Targeting dna repair to eradicate tki-refractory/resistant cml
  • Targeting epigenetic regulation to disrupt glioma stem cell maintenance.
  • Targeting ezh2 in germinal center derived b-cell lymphoma
  • Targeting gain-of-function p53 missense mutants
  • Targeting glioma stem cells by perturbation of telomere maintenance mechanisms
  • Targeting lymphoma with modular anti-idiotype peptibodies
  • Targeting metabolism in leukemic stem cells
  • Targeting mucin and egfr axis in pancreatic cancer
  • Targeting nedd8-mediated protein turnover in aml
  • Targeting neuroblastoma with armed t cells
  • Targeting n-linked glycosylation to enhance radiation therapy
  • Targeting ovarian cancer via cooperative oncogene interactions
  • Targeting pancreatic cancer energy metabolism, tumor growth, and metastasis
  • Targeting sirt1 in mantle cell lymphoma
  • Targeting spleen tyrosine kinase in chemoresistant ovarian carcinoma
  • Targeting stem-cell dependent drug resistance in human mcl
  • Targeting tf/cd44v6 for in vivo nano-generated alpha-therapy of ovarian cancer
  • Targeting the chondrosarcoma extracellular matrix for drug delivery
  • Targeting the c-met/hgf axis in acute myeloid leukemia
  • Targeting the core binding factor tumor suppressor in mll-fusion aml
  • Targeting the g-csf/stat3 signaling pathway in neuroblastoma cancer stem cells
  • Targeting the tumor microenvironment in b-cell malignancies
  • Targeting tumor-microenvironment interaction to overcome leukemia chemoresistance
  • Targeting tumor-stromal interaction for pancreatic cancer therapy
  • Tethered cationic lipoplex nanoparticle assay for liver cancer detection and surv
  • The addition of fish oil to sorafenib may prevent kidney cancer metastasis
  • The biochemical contributions of ovulation to fallopian tube tumorigenesis
  • The development of novel inhibitors of bcl2 gene expression as anticancer therape
  • The feasibility of self or partner-assisted digital anal exam screening
  • The mechanisms driving brain oncogenesis by fgfr-tacc gene fusions
  • The molecular mechanism of isocitrate dehydrogenase (ldh) mutations in cancer
  • The pluripotency regulator prdm14 initiates cancer by epigenetic mechanisms
  • The regulation of cisplatin resistance in ovarian cancer
  • The role and functional mechanism of tet1 in mll-rearranged leukemia
  • The role of ampk signaling in the anti-leukemic effects of arsenic trioxide
  • The role of atrx and h3.3 mutations in pediatric glioblastoma
  • The role of cereblon pathways in myeloma
  • The role of chd5 in chromatin-mediated regulation of neural stem cells and glioma
  • The role of cidofovir and structural analogs as adjuvant therapy for glioblastoma
  • The role of egln1 and hif in normal hematopoiesis and in leukemia
  • The role of exosome heparanase and mirnas as biomarkers for myeloma
  • The role of fak in hepatocarcinogenesis
  • The role of lin28b in wilms tumor
  • The role of mdm2-mtbp axis in cancer metastasis
  • The role of nfat3 in quiescence and chemoresistance in ovarian cancer stem cells
  • The role of nup88 overexpression in cellular transformation and tumorigenesis
  • The role of probiotic bifidobacteria and bile acid metabolism in carcinogenesis
  • The role of rb phosphorylation in proliferation and apoptosis of breast cancer ce
  • The role of ship-1 in the modulation of immunoregulatory cells in pancreatic canc
  • The role of the fanconi anemia pathway in human papillomavirus infection
  • The role of the protein tyrosine phosphatase prl3 in leukemia development
  • The role of viral and cellular mirnas in b-cell lymphomagenesis
  • The targeting of the hif switch in kidney cancer
  • The thrombospondin1-tgf-beta axis in multiple myeloma
  • The tumor suppressive role of the mir-200 family of micrornas
  • The use of epigenetic therapy to activate an immune response in ovarian cancer
  • The yap-tead transcriptional complex in kras-induced pancreatic ductal adenocarci
  • Therapeutic antibody discovery from pancreatic cancer b cell repertoires
  • Therapeutic elimination of stem cells for relapsed pediatric aml
  • Therapeutic in situ vaccination for human lymphoma
  • Therapy of pancreatic cancer with 212pb-labeled b7-h3 specific ab and lde225
  • Three-dimensional model of human ewing sarcoma
  • Tools to analyze morphology and spatially mapped molecular data
  • Towards the chemotherapy-free treatment of follicular lymphoma
  • Trail upregulation by tic10 analogs
  • Transcription-dependent and -independent signaling of rsk2 in cancer metastasis
  • Transition from endometriosis to ovarian cancer: role of iron-induced autophagy
  • Translesion dna polymerase kappa activity in gliomas
  • Trem-1 and its implications to cancer
  • Trial participation decision making in ovarian cancer patients and their families
  • Trib1 in nf-kappab signaling: insights into malt1 regulation and leukemia
  • Trisomy 8 in hematopoiesis and myeloid leukemia
  • Tsc1/mtor axis in immune homeostasis and tumorigenesis
  • Tumor suppressor rassf2 in t(8;21) acute myeloid leukemia
  • Tumor tight junction opener + chemotherapy conjugates to treat cancer
  • Tumor-cell-specific targets for combined hyperthermia and radiation effects
  • Two-photon fluorescence lifetime microscopy for breast and thyroid cancer margin
  • Tyrosine kinase inhibition and immunomodulation for cancer
  • Ubiquitin based therapy of aggressive cancer cell populations
  • Uncovering the anti-apoptotic mechanism of mutated alk in neuroblastoma
  • Unleashing the efficacy of pi3k/akt/mtor pathway inhibitors in b-all
  • Unraveling glutamine metabolism in gliomas by pet imaging and biochemical methods
  • Unusual evolutionary patterns in brca1 and their implications for cancer
  • Upregulation of nanog as an innovative mechanism for cancer drug resistance.
  • Use of dnd1 to counteract mirna function in cancers
  • Using donor pdc to optimize gvhd and gvl in allogeneic stem cell transplantation
  • Using stat3 signaling profiles to understand chemotherapy resistance in aml
  • Utility of effusion cytology and image analysis in the diagnosis of mesothelioma
  • Utilizing hur to optimize the treatment of pancreatic cancer
  • Utx, mll and pathogenic deregulation of histone methylation in multiple myeloma
  • Validating technology to optimize antibody affinity for targeting therapeutics
  • Validating the prognostic value of egfr768 in neuroblastoma
  • Validation of a novel treatment for glioblastoma
  • Validation of findings from the epigenome-wide association study of breast cancer
  • Varicella virus antigens in glioma etiology and survival
  • Virus discovery and characterization in large-scale cancer sequencing data
  • Vlr-cart cancer immunotherapy
  • Zileuton as a chemopreventive agent for chronic myeloid leukemia
  • Zinc chemoprevention of arsenic co-carcinogenesis
  • Znf-mediated resistance to imatinib mesylate in gastrointestinal stromal tumor

 

2013

  • A Drug Delivery Strategy for Targeted Therapy of Chronic Lymphocytic Leukemia (website)
  • A Novel Brachytherapy Agent for GBM (website)
  • A novel photopatterning-based paradigm for the study of 3D tumor infiltration (website)
  • A Pathway-based Approach to Investigate Oncogenic Mechanisms in Ovarian Cancer (website)
  • A Structure/Function Analysis of CTC1 Using Coats plus/DKC Mutations (website)
  • A Surviorship Planning Tool for Head and Neck Cancer Patients and Caregivers (website)
  • Academic-Industrial Partnership to Develop Clinical Brain Cancer Imaging (website)
  • Activity-Based Kinase Discovery In Small Cell Lung Cancer (website)
  • Alpha Radioimmunotherapy for Lymphoma Treatment (website)
  • Alternative Cleavage and Polyadenylation Events as Biomarkers (website)
  • Analysis of Initiating Events in Inv(16) Associated Acute Myeloid Leukemia (website)
  • Angiocidin, a Novel Differentiation Agent for the Treatment of Leukemia (website)
  • Anit-PR1 Immune Therapy for Myeloid Leukemia (website)
  • Annexin A2 as a Novel Enhancer of Tumor-Associated Antigen Processing (website)
  • Antagonizing oncogenic microRNAs for the elucidation and treatment of lymphoma (website)
  • Anti-pancreatic tumorigenesis by inactivation of SAG/RBX2 E3 ubiquitin ligase (website)
  • Apoptosome Regulation in Leukemia by Protein Phosphatase 5 Hypoacetylation (website)
  • Autophagy in Pancreatic Neuroendocrine Tumor Growth and Metastasis (website)
  • Axl as a target for the therapy of pancreatic cancer (website)
  • B7H1 Mediated Immunosuppression in Glioma (website)
  • B7-H1 mediated immunosuppression in immunocompetent animal model of gliomas (website)
  • BET bromodomain inhibition as targeted therapy in acute myeloid leukemia (website)
  • Biologic and therapeutic relevance of DNMT3A mutations in acute myeloid leukemia (website)
  • Biologic Basis of Disparity in Liver Cancer Survival Among Asian Americans (website)
  • Biomaterials for treatment of head and neck cancer (website)
  • Bone and Soft Tissue Tumor Etiology: Role and Function of TRE17/USP6 (website)
  • Brain Tumor Sport Grant (website)
  • Carbonyls to Cancer Therapeutics (website)
  • Cellular and molecular basis of microRNA-29a Induced Acute Myeloid Leukemia (website)
  • Characterizing tumor suppressive functions of microRNAs in B-cell neoplasia (website)
  • Chemical Genetic Dissection of Aurora A in Promoting EMT and Stem Cells Phenotype (website)
  • Chemosensitization of Pancreatic Cancer Cells by Curcumin and Vitamin D Receptor (website)
  • Chromatin Regulation of KSHV Primary Infection (website)
  • Circulating tumor cells in hepatocellular carcinoma (website)
  • Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas (website)
  • Classifying DNA Mismatch Repair Gene Variants of Unknown Significance (website)
  • Comb External Beam Radiotherapy with 153Sm-EDTMP to Treat High Risk Osteosarcoma (website)
  • Combination therapies with interleukin-21 in chronic lymphocytic leukemia (website)
  • Companion Diagnostic for Multiple Myeloma (website)
  • Crenolanib and ponatinib for the treatment of FLT3 mutant AML (website)
  • Decision Models to Compare Treatments in Older Patients with AML (website)
  • Defining a Molecularly Distinct Subtype of Non Small Cell Lung Cancer (website)
  • Defining mechanisms of extracellular communication for cancer therapy (website)
  • Deregulated microRNAs in Acute Myeloid Leukemia (website)
  • Determining the Roles of ATRX and DAXX Abnormalities in Cancer Telomere Biology (website)
  • Development and Validation of Novel Circulating Medullary Thyroid Cancer Markers (website)
  • Development of New Therapeutics for Pancreatic Cancer Management (website)
  • Development of TAK1 Inhibitors to Treat Pancreatic Cancer (website)
  • Development of Therapeutic CD59 inhibitor for treating B-cell malignancies (website)
  • Dietary Selenium, Selenoenzyme Genes and Adult Glioma (website)
  • Direct Delivery of Immune-modulating Therapies to the Pancreatic Tumor Site (website)
  • Discovery and Evaluation of Prioritized Mutations in Pancreatic Cancer (website)
  • Dopamine as a therapeutic agent in stomach cancer (website)
  • Effect of anti-S phase agents on human chromosomes (website)
  • EGFR Activation in H. Pylori-Induced Gastric Cancer (website)
  • Elafin as a biomarker in serous ovarian cancers and basal-like breast tumors (website)
  • Elucidating the Role of MiR-31 in Retinoblastoma Invasion (website)
  • Epi)Genomic drivers of primary and metastatic pancreatic islet cell carcinoma (website)
  • Epigenetic Modulation of GvHD and GvL (website)
  • Epigenetic profiling of hepatoblastoma tumors with respect to low birth weight (website)
  • Epigenetics and Epigenetic Therapy in AML (website)
  • Epigenomic determinants of clinical outcomes in MCL patients treated on E1405 (website)
  • Esophageal Cancer from Cells to Population: A Multiscale Approach (website)
  • Estrogen Receptor Targeted Treatment Of Non-Muscle Invasive Bladder Cancer (website)
  • Evaluation of HCC Response to Systemic Therapy with Quantitative MRI (website)
  • Evaluation of MSP Antagonists for the Treatment of Pancreatic Cancer (website)
  • Evaluation of Patient-Matched Primary and Metastatic Samples to Identify and Vali (website)
  • Ewing’s Sarcoma Resistance to Immunity and Radiation (website)
  • Exploiting tumor stroma interactions for cancer therapy (website)
  • Exploring Sarcoma Metastatic Potential (website)
  • Flt3L Treatment of Pancreatic Cancer (website)
  • Functional Evaluation of Human Pancreatic Cancer Genes in a Zebrafish System (website)
  • Functional Evaluation of microRNAs in Pancreatic Neoplasia (website)
  • Gastric Histopathology Core (website)
  • Gene Methylation Signatures for Predictive Classification of Response to Therapy (website)
  • Generation of humanized mouse model of medulloblastoma (website)
  • Genetic network analysis of cancer targets (website)
  • Genetic Risk Prediction in Primary Care (website)
  • Genetic Susceptibility and Risk Model for Pancreatic Cancer (website)
  • Genetically-Modified Neural Stem Cell Based Virotherapy for Invasive Gliomas (website)
  • Genome instability and epigenetic deregulation in retinoblastoma and osteosarcoma (website)
  • Genome-wide Case-control Association Study of Pancreatic Cancer in Jews (website)
  • Genotype and phenotype of chemoresistant AML (website)
  • Germline KLLN Alterations in PTEN Mutation Negative Cowden Syndrome (website)
  • Glioma immunotherapy with strategies based on autonomous parvovirus MVMp (website)
  • Grp94 targeted therapy for pancreatic ductal adenocarcinoma (website)
  • HDAC3 – a therapeutic target in PDA (website)
  • Hedgehog EGF Pathway Interaction: Novel Multi-Target Therapy Pancreatic Cancer (website)
  • Helicobacter pylori cag Pathogenicity Island and Gastric Carcinogenesis (website)
  • HIF-2alpha mediated mitophagy and lipogenesis in clear cell renal cell carcinoma (website)
  • High Throughput Screening (HTS) to Discover Graft-Versus-Host Disease Inhibitors (website)
  • HIV-driven B cell activation: role in the genesis of AIDS-related lymphoma (website)
  • Human cytomegalovirus in the promotion of glioblastoma multiforme pathogenesis (website)
  • Hypersensitivity of Multiple Myeloma Bone Disease to Vitamin D (website)
  • Hypoxia-Selective Kinase Inhibitors for Leukemia Therapy (website)
  • Identification of KSHV miRNA targets in endothelial cells and characterization mi (website)
  • Identification of Melanoma Brain Metastasis Tumor Biomarkers (website)
  • Identifying Cell Stress Proteins that Predict Clinical Response in Pediatric AML (website)
  • Identifying Regulators of Oncogenic CARD11 in Diffuse Large B Cell Lymphoma (website)
  • IDO-silencing Salmonella therapy for the treatment of primary and metastatic PDAC (website)
  • IGF1R gene 3′UTR variants in high-risk pediatric neuroblastoma (website)
  • Imaging Guided Genomics of Malignant Transformation (website)
  • Impact of B-Cell Lineage on Progression of B-Acute Lymphoblastic Leukemia (website)
  • Impact of BRCA Testing on Newly Diagnosed U.S. Breast Cancer Patients (website)
  • Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR (website)
  • Improving Pancreas RT Plans using Respiration-driven Anatomic Deformation (website)
  • In vivo imaging of encapsulated stem cells in mouse models of tumor resection (website)
  • In vivo therapy and mechanisms of PAX8-PPARgamma thyroid cancer (website)
  • Incorporating FLT3 Inhibitors into Acute Myeloid Leukemia(AML)Treatment Regimens (website)
  • Indirubins: novel anti-invasive and anti-angiogenic drugs for malignant gliomas (website)
  • Inflammatory processes In diet-Induced pancreatic cancer promotion (website)
  • Inhibiting VHL-positive kidney cancer (website)
  • Inhibitors of IgH Gene Enhancers for the Treatment of Multiple Myeloma (website)
  • Inhibitory targeting of HHV-8 vIL-6-related interactions (website)
  • Innovative approach to cancer detection and treatment monitoring (website)
  • Interleukin-8 Regulation by Proteasome and Nuclear IkB in Cancer and Inflammation (website)
  • Interplay between intrinsic and extrinsic force and glioma aggression (website)
  • Intraoperative imaging of breast cancer margins using Polarization Subtraction Te (website)
  • Invasion of glioblastoma multiforme (GBM) cells in organotypic brain slices (website)
  • Investigating MicroRNAs and Their Regulatory Networks in Glioblastoma (website)
  • Investigating YAP’s role during pathogenesis of pancreatic ductal adenocarcinoma (website)
  • Investigation of a novel regulator of Myc-driven tumorigenesis (website)
  • KSHV Abortive Replication Following De Novo Infection (website)
  • KSHV genome modification in KS tissue (website)
  • KSHV Persistence and Pathogenesis (website)
  • LncRNA Pathways as Novel Diagnostic Biomarkers Derived from the Stroma of Epithel (website)
  • LuIII parvovirus targets glioma (website)
  • MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL (website)
  • Mechanism of action of Prdm16 in hematopoietic stem cells (website)
  • Mechanisms and Function of Autophagy in Cancer (website)
  • Mechanisms of acquired temozolomide resistance in glioblastoma multiforme (website)
  • Mechanisms of action of the Smyd3 methyltransferase in cancer cells (website)
  • Mechanisms of PPM1D in medulloblastoma tumorigenesis and invasion (website)
  • Mechanisms Promoting Angiogenesis in Glioblastoma (website)
  • Mechanistic Dissection of the Fanconi Anemia Pathway of DNA Damage Response and R (website)
  • Metabolic Reprogramming in Brain Tumors (website)
  • Metronomic Small Molecule Inhibitor of Bcl2 in Head and Neck Cancer Therapy (website)
  • Microbiomes in Human Pancreatic Cancer (website)
  • Microenvironmental impact on HNSCC response to targeted therapy (website)
  • Microenvironment-Leukemia Communication Through Lectins (website)
  • Minimal Residual Disease Monitoring by T-cell Receptor Repertoire Profiling (website)
  • MiR-182 overexpression in early tumorigenesis of high grade serous carcinoma (website)
  • Molecular Biology of Lung Cancer among Puerto Ricans (website)
  • Molecular Fluorescence-Guided Surgery Platform (website)
  • Molecular Imaging of Metastatic Potential in SCCHN by Targeting VLA-4 and CXCR4 (website)
  • Molecular Mechanisms of Prostate Cancer Induced Bone Remodeling (website)
  • Molecular Mediators of Pancreatic Cancer Invasion and Progression (website)
  • Molecular Target Variation Across Environments and at Margins of Glioblastoma (website)
  • Motion Management Using 4D-MRI for Liver Cancer in Radiation Therapy (website)
  • Mouse models of glioma to study functional exRNA transfer to the microenvironment (website)
  • MR Image Guided Gynecologic Brachytherapy (website)
  • MR Investigation of IDH Mutation and Its Marker 2-HG in Brain Tumor Patients (website)
  • MR-Guided Precision Conformal Ablation Therapy for Brain Tumors (website)
  • MUC1 enhances Neuropilin-1 signaling in pancreatic ductal adenocarcinoma (website)
  • MUC1 regulation of TGF-beta function in pancreatic cancer cells (website)
  • Mucus Penetrating Nanoparticles for Small Cell Lung Cancer (website)
  • Multifunctional immunoPET tracers for pancreatic and prostate cancer (website)
  • Multifunctional nanoparticles to improve treatment of human glioblastoma (website)
  • Nanoparticle Enabled L-asparaginase Therapy for CLL (website)
  • Nanoparticle formulations of DNA repair inhibitors to improve chemoradiotherapy (website)
  • Next Generation Oncolytic Adenovirus for Advanced Pancreatic Cancer Treatment (website)
  • NMDA receptors in the diagnosis and treatment of pancreatic cancer (website)
  • Noninvasive measurement of oncogenic signaling pathways with 89Zr-transferrin (website)
  • Non-Oncogene Addiction as a Targeted Therapy for Pancreatic Cancer (website)
  • Novel adhesion mechanisms in glioblastoma stem cells (website)
  • Novel Anti-HER3 Strategy for Pancreatic Cancer (website)
  • Novel Approacahes For Improving Pediatric Brafv600e Glioma Patient Outcomes (website)
  • Novel Biomarkers Of Malignant Progression In Recurrent Low Grade Glioma (website)
  • Novel Cell Cycle Therapeutic Targets in Pancreatic Cancer (website)
  • Novel Chemotherapeutics for Brain Tumors (website)
  • Novel lysine deacetylase 6 Hsp domain inhibitors against AML (website)
  • Novel Nanoparticle Therapy for Pancreatic Cancer (website)
  • Novel Role of Ref-1 in Pancreatic Cancer Etiology and Progression (website)
  • Novel Targeted Therapy for AML (website)
  • Novel treatment strategies for enhancing sunitinib response in renal cell cancer (website)
  • Novel Vitamin B6 based prodrugs of gemcitabine (website)
  • Optimizing 131I-mIBG Therapy for Children with Advanced Neuroblastoma (website)
  • Optimizing selective in vivo inhibition of pancreatic tumor JAK2/STAT3 signaling (website)
  • Oral Biomarkers for HPV-related Head and Neck Cancer (website)
  • Osteosarcoma in Dogs as a Model for the Development of Drugs to Treat Micro-metas (website)
  • Overcoming Inferior Quality of Vaccine Responses After Alkylating Chemotherapy (website)
  • Overcoming Local And Peripheral Immune Suppression In Glioma To Facilitate Effec (website)
  • Overcoming Resistance to Anti-VEGF Treatment of Glioblastoma (website)
  • Overcoming Temozolomide Resistance using MGMT-targeting Spherical Nucleic Acids (website)
  • P53 Activation as Novel Therapeutic Strategy for Acute Myelogenous Leukemia (website)
  • Pancreatic Cancer-Associated Diabetes: Pathogenesis and Biomarkers (website)
  • PARP Inhibition To Enhance Induction for Head and Neck Cancer (website)
  • Peptide vaccine-based immunotherapy for children with recurrent ependymomas (website)
  • Pharmacogenetics in children with high-risk neuroblastoma (website)
  • PKA and follicular thyroid carcinogenesis: Roles of interacting pathways (website)
  • Plasma Biomarkers of Acute Graft Versus Host Disease (website)
  • Polysomy 21 in Acute Lymphoblastic Leukemia (website)
  • PQA4) Point-of-Care Test of Exposure to Hepatocellular Carcinoma Risk by V-Chip (website)
  • Profiling Pancreatic Cancer Metabolism and Tumor Microenvironment for Therapy (website)
  • Quantitative MRSI to predict early response to SAHA therapy in new GBM management (website)
  • Rab Geranylgeranylation: a Novel Therapeutic Target in Multiple Myeloma (website)
  • Radioactive Stents for Brachytherapy of Esophageal Cancers (website)
  • Recombinant Polymers for Transarterial Chemoembolization of Liver Cancer (website)
  • Regional Quantification of Lung Function in Cystic Fibrosis using Xe129 MRI (website)
  • Regulation and function of Six1 in zebrafish muscle development and in rhabdomyos (website)
  • Regulation of Hypoxia-inducible Factor 1 by Cyclin Dependent Kinases (website)
  • Regulation of molecular thermal ablative resistance in hepatocellular carcinoma (website)
  • Regulation of Tumor Metabolism by Retinoblastoma Protein (website)
  • Restoring anti-tumor immunity in the microenvironment of head and neck cancer (website)
  • RNA Splicing Modulators for MDS/AML (website)
  • RNAi screen for chromatin regulators of differentiation in Acute Myeloid Leukemia (website)
  • Role of a Novel Homeobox Transcription Factor (HLX) in Acute Myeloid Leukemia (website)
  • Role Of Aca11, An Orphan Small Nucleolar Rna In Resistance To Cancer Chemotherapy (website)
  • Role of CCR2+ monocytes and Mo-DCs in defense against IA and GVHD development (website)
  • Role of Id1 in adiposity, energy balance and obesity associated liver tumorigenes (website)
  • Role of IRF-1 dependent chemokines in glioma (website)
  • Role of IRF4-NOTCH2 Interplay in B-Cell Development and Malignancy (website)
  • Role of LANA-RBP-jk During Early KSHV Infection (website)
  • Role of microRNA-124 in counteracting glioblastoma adaptation to cellular stress (website)
  • Role of MLL2 Gene Inactivation in B cell Non Hodgkin Lymphoma (website)
  • Role of Neurogenic Inflammation in Pancreatic Cancer (website)
  • Role of NFxB/HIF2a axis in renal cell carcinoma progression (website)
  • Role of Obesity-Induced Immunosuppression in Pancreatic Cancer (website)
  • Role of Tcl1 and Par-4 in regulation of chronic lymphocytic leukemia (website)
  • Role of TET2 mutations in malignant transformation and acute myeloid leukemia (website)
  • Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation (website)
  • Roles of MicroRNAs in KSHV Persistence and Pathogenesis (website)
  • Roles of Nucleotide Metabolic Control in KSHV Persistence (website)
  • Roles of the K3 and K5 in KSHV Persistence and Pathogenesis (website)
  • Screening for modulators of glioma stem cells differentiation (website)
  • Sensitizing Leukemia Stem Cells to NF-kB Inhibition by Blocking TNF Signaling (website)
  • Sleeping Beauty Mediated Therapy for Alpha V Beta 6-Expressing Pancreatic Cancer (website)
  • SPARC as a regulator of collagen signaling in Pancreatic Cancer (website)
  • SPORE: Targeted Therapies for Glioma (website)
  • Studies of Childhood Sarcomas (website)
  • Suppression of BCR-ABL by siRNA-loaded Nanoparticles for the Treatment of CML (website)
  • Survival Bump Hunting for Finding Informative Subgroups in High Dimensional Data (website)
  • Swallow Function and Oral Morbidities in RT Treated Head/Neck Cancer Survivors (website)
  • Synergistic interactions between SapC-DOPS and chemotherapy for glioma (website)
  • Synthesis of Vinblastine Analogues with Improved Physiochemical Properties (website)
  • Systemic Nanocurcumin for Pancreatic Cancer Therapy (website)
  • Targeted Docetaxel-Nanocolloid for the Treatment of Ovarian Cancer (website)
  • Targeted Elimination of Cancer Stem Cells for AML Therapy (website)
  • Targeted Sphing »omics »Core (website)
  • Targeted Sphingolipid Metabolism for Treatment of AML (website)
  • Targeted Therapies and Mechanisms of Resistance in Chronic Lymphocytic Leukemia (website)
  • Targeted Therapy for AML Stem Cells (website)
  • Targeted Therapy for Lymphoid Malignancies (website)
  • Targeting Acid Ceramidase in AML (website)
  • Targeting AML with PI3K/AKT inhibitors and BH3-mimetics (website)
  • Targeting Antigen-Induced Er Stress Response In B-Cell Chronic Lymphocytic Leukem (website)
  • Targeting B-cell lymphoma with Leukothera (website)
  • Targeting Caregivers to Enhance Health Behaviors in Pediatric Cancer Survivors (website)
  • Targeting Ceramide Glycosylation in AML (website)
  • Targeting Ceramide Metabolism in AML (website)
  • Targeting c-Myc and Akt with PP2A reactivation therapy for the treatment of breas (website)
  • Targeting CXCR4 and microRNA as Therapy for Chondrosarcoma (website)
  • Targeting Deep Brain Tumors with MRI-Insertable Magnetic Gradients and Nanopartic (website)
  • Targeting DEPTOR in multiple myeloma (website)
  • Targeting glioma stem cells by perturbation of telomere maintenance mechanisms (website)
  • Targeting IL-12/23 p40 Pathways for the Control of GVHD (website)
  • Targeting Pancreatic Cancer with Aptamers to the CCK-B Receptor (website)
  • Targeting Radiation Resistance in Glioblastoma Stem Cells (website)
  • Targeting RAGE in pancreatic cancer (website)
  • Targeting Sphingosine Kinase in AML (website)
  • Targeting Stromal Collagen in Pancreatic Cancer (website)
  • Targeting the Bone Marrow Microenvironment In Acute Lymphocytic Leukemia (website)
  • Targeting the C/EBPalpha-Gfi-pathway in CML stem cells (website)
  • Targeting the IDH Pathway (website)
  • Targeting the MLL-WDR5 protein-protein interaction (website)
  • Targeting the OLIG2 Transcription Factor (website)
  • Targeting the PI3K Signaling Axis (website)
  • Targeting the translational apparatus in MYCN-driven pediatric solid tumors (website)
  • Targeting the Urokinase Receptor in Glioblastoma Multiforme (website)
  • Targeting y-secretase in GVHD (website)
  • The Function of EBV LMP1 CTAR3 in Sumoylation and Oncogenesis (website)
  • The Hippo Signaling Pathway in Pancreatic Cancer (website)
  • The Impact of Treatment Adherence on A Clinical Biomarker in Pediatric Acute Lymp (website)
  • The Oncogenic Role of miR-9 in MLL-Associated Leukemias (website)
  • The role of ETV6 in T-cell acute lymphoblastic leukemia (website)
  • The Role of FBXL4 in T-cell Acute Lymphoblastic Leukemia (website)
  • The Role of Growth Factor Receptor Trafficking in Tumorigenesis (website)
  • The role of HO-1 in Flt3-ITD positive AML proliferation and drug resistance (website)
  • The role of ICSBP in the pathogenesis of chronic myeloid leukemia (website)
  • The role of inhibitory receptors in leukemia development (website)
  • The Role of JAB1 in osteosarcoma pathogenesis (website)
  • The role of MTG8 in transcriptional elongation and leukemia (website)
  • The Role of NOTCH1 in the Pathogenesis of CLL (website)
  • The Role of Post Traumatic Stress and Substance P in Melanoma Brain Metastasis (website)
  • The role of the stromal cell surface protease FAP in pancreatic cancer (website)
  • The study of novel miRNA in lung cancer initiation and metastasis (website)
  • The Tribbles-COP1 Complex in Leukemia (website)
  • The Welfare Consequences of Oncology Drug Shortages (website)
  • Therapeutic Targeting of Leukemia-Microenvironmental Interactions (website)
  • TLR4 in obesity-driven liver cancer (website)
  • Toll-like Receptor Regulation of Pancreatic Tumorigenesis (website)
  • Transcriptional Coregulation in Pancreatic Adenocarcinoma Progression (website)
  • Translating Novel Drug-Targetable Biomarkers to Treat Graft versus Host Disease (website)
  • Translation of Novel Therapeutic Targets in Multiple Myeloma (website)
  • Tumor antigen-specific T-cells and hepatocellular carcinoma (website)
  • TXNIP as a regulator of thyroid cancer aggressiveness (website)
  • Understanding the role of altered metabolism in gliomagenesis (website)
  • Unmetabolized folic acid and retinoblastoma (website)
  • Urinary metalloproteinases and ovarian cancer risk in a prospective cohort (website)
  • Viral oncoprotein targeted immune therapy for Merkel cell carcinoma (website)
  • Women’s Health Initiative Cancer Survivor Cohort (website)

2012

  • 5-hydroxymethylcytosine in human cancer (website)
  • A Drosophila Model Linking Diet-induced Obesity and Cancer (PQ 1) (website)
  • A Highly Multiplexed PCR Platform for Gene Expression Profiling from FFPE Tissue (website)
  • A Multi-Purpose Nanovehicle for Targeted Boron Neutron Capture Cancer Therapy & I (website)
  • A Novel Approach for the Routine Screening for Ovarian Cancer (website)
  • A novel diagnostic biomarker for hepatocellular carcinoma and cholangiocarcinoma (website)
  • A Novel Lineage Specific Metastasis Suppressor Pathway in Lung Cancer (website)
  • A novel model system for risk assessment of BRCA carriers (website)
  • A novel murine model for metastatic islet cell pancreas cancer (website)
  • A Predictive Prognostic Model for Glioblastoma Multiforme (website)
  • A role for elevated autophagy in survival and chemoresistance of leukemia stem ce (website)
  • A Role for Fatty Acid Binding Protein 4 in Ovarian Cancer Metastasis (website)
  • A Small Molecule to Activate Cetuximab to Kill K-RAS Mutant Colorectal Tumors (website)
  • A Translational Model of Evolution of Myeloma Adhesion-Mediated Drug Resistance (website)
  • Aberrantly secreted glycoproteins as markers of liver cancer (website)
  • ADAM17 in pancreatic cancer and pancreatitis (website)
  • Adoptive transfer of gene-modified autologous T-cells post-ASCT for myeloma (website)
  • Aflatoxin B1 hepatocarcinogenesis in the mGSTA3-/- mouse (website)
  • Alchol Abuse and Metabolic Syndrome Promote Desmoplasia of Pancreatic Cancer (website)
  • Aldo-keto reductase family 1 member B10 AKR1B10 in pancreatic carcinogenesis (website)
  • Alliance of Glycobiologists for Detection of Cancer (website)
  • Alternative RNA splicing and protein products in leukemia outcome (PQ11) (website)
  • Amplifying Radiation Potency Against Leukemic Stem Cells (website)
  • An adenoviral/piggyBac hybrid system to accelerate cancer gene validation(PQ #9) (website)
  • An Integrated Approach to the Validation of Novel Gastric Cancer Oncogenes (website)
  • An Orthotopic Murine Model of HCC: Immunotolerance and Prevention (website)
  • Analysis of Risks and Outcomes for Rare Cancers (website)
  • Animal model of Gardner’s syndrome, a life threatening form of familial cancer (website)
  • Antibody directed delivery of short interfering RNA for the treatment of ovarian (website)
  • Anticancer Drug Pharmacology in Very Young Children (website)
  • Anticancer drug-induced BH3-only protein.Bak interactions (website)
  • Antiprogestin therapy for ovarian cancer (website)
  • Antiretroviral Therapy Strategies to Lower Cancer Risk in HIV-Infected Persons (website)
  • Anti-Tumor Immunity in Response to a Modified Vaccine Strain Measles Virus (website)
  • Aptamer targeting of osteopontin in hepatocellular cancer (website)
  • Ascorbate-Induced Radiosensitization In Pancreatic Cancer (website)
  • Assaying GBM growth and therapy response in single cells and tumorspheres (PQ17) (website)
  • ATP-Dependent Chromatin Remodeling in Human Malignancy (website)
  • Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer (website)
  • Axl receptor signaling in MPNST; potential node for therapy (website)
  • B7-H1 Signaling in Ovarian Cancer (website)
  • Biological Variants Underlying Racial Differences in Lymphoma (website)
  • Bmi-1, a potential therapeutic target in ovarian cancer (website)
  • Brain Tumor-Penetrating Nanoparticle Delivery with MR-Guided Focused Ultrasound (website)
  • Bypassing Oncogene Addiction: Mechanisms of off-target resistance in CML (website)
  • Ca2+/CaM-Dependent Protein Kinase II: A Novel Target in Osteosarcoma (website)
  • Cadherin11 in cancer & rheumatoid arthritis: Common target, common therapies? (5) (website)
  • Cancer Cell Overexpression of Death Receptor Modulator (website)
  • Cancer cell signaling through lipids complexed to proteins (website)
  • Cancer epigenetics: Understanding histone methylation in leukemia stem cells (website)
  • Cancer risk after renal transplant in autoimmune disease (website)
  • Capsaicin and Small cell Lung Cancer Therapy (website)
  • CC49/RIGS, a diagnostic radiopharmaceutical monoclonal antibody, for enhanced liv (website)
  • CD147 Biological Function and Role as a Biomarker of MGUS to Myeloma Progression (website)
  • CD19 Directed CAR Therapy (website)
  • CD20-targeted IL-15 immunotherapeutic for B-cell malignancies (website)
  • Cdk4/6 Inhibitor Therapy for Glioblastoma Multiforme (website)
  • Cell invasion, motility, and proliferation level estimate maps in gliomas (website)
  • Cell signaling as a leukemia biomarker (website)
  • Cell-specific analysis of transcription and epigenomic status in PDAC (website)
  • Cellular Mapping of Small Molecule/Nucleic Acid Interactions (website)
  • Cellular plasticity and survival mechanisms in medulloblastoma stem cells (website)
  • Characterization and Development of a Coiled-Coil to Treat Non-Hodgkin Lymphoma (website)
  • Characterization And Targeted Therapy Of T-All Deficient For Pten And Ink4a/Arf (website)
  • Characterization and Targeting of Immune-evasive Adaptations in Early Neoplasms (website)
  • Characterization of a T cell dysfunctional state induced in mice with AML (website)
  • Characterization of antitumor auto-antibodies using combinatorial peptide librari (website)
  • Characterization of ER-localized Activity of HHV-8 Interleukin-6 (website)
  • Characterization of lcmt in Animal Models of Cancer (website)
  • Characterization of the LGL Leukemia Virus (PQ 12) (website)
  • Chemical Optimization Designed to Increase the in vivo Efficacy of HM-27 for the (website)
  • Chemoprevention of pancreatic cancer witli antidiabetic agents (website)
  • Chemotherapy resistance in ALL: role of the bone marrow microenvironment (website)
  • Chronic Convection Enhanced Delivery (Ced) Of Topotecan For Glioblastoma (website)
  • CMV Therapeutic Vaccine for the Treatment of Glioblastoma (website)
  • Combination immunotherapy for neuroblastoma: model of innate tumor immunity (website)
  • Combined Pre & Intraoperative Brain Tumor Imaging Strategy using a Dual-Modality (website)
  • Comparative Genomics Study of Foxa/ER Targets in Liver Cancer and Breast Cancer (website)
  • Complications of Jaw Osteoradionecrosis in Cancer Management (website)
  • Comprehensive Evaluation of OGSE DWI for Assessing Tumor Treatment Response (website)
  • Computational and Functional Approaches To Validating Cancer Genome Targets (website)
  • Construction And Testing Of A Trivalent Vaccine Against Neuroblastoma Administere (website)
  • Continuous Chromatography Device to Economically Purify Clinical-grade Antibodies (website)
  • Convergence of CREB and MYC Pathways in Oncogenesis (website)
  • Coordinate Regulation of p53 and c-MYC in an HTLV-1 Model of Carcinogenesis (website)
  • Cotranslational Functions of MTOR (website)
  • Cyclin requirements in gammaherpesvirus infection and disease (website)
  • Cyclophosphamide modified GM-CSF pancreatic tumor vaccine + listeria-mesothelin (website)
  • CYP1B1: A Molecular Target for Chemoprevention of Lung Adenocarcinoma (website)
  • Cytochrome C Oxidase in Malignant Gliomas (website)
  • DDR2 kinase inhibition in squamous cell lung carcinomas (website)
  • Deciphering the Tissue Specificity of MEN1 Related Tumorigenesis (website)
  • Defining mechanisms and targets in Wnt addicted human malignancies (PQ22) (website)
  • Defining PI3K p110alpha as a therapeutic target in pancreatic cancer (website)
  • Defining the metabolic phenotype of low grade gliomas in vivo (website)
  • Defining the role and regulation of the RhoGEF Ect2 in ovarian cancer cells (website)
  • Delta-like ligand 4+ dendritic cells and induction of alloimmunity (website)
  • Design of MEK Inhibitor Regimens for the Treatment of Pancreatic Cancer (website)
  • Detection of Light Chain Restriction in non-Hodgkin Lymphoma by a Novel RNA In Si (website)
  • Development of a diagnostic biomarker for Ewing’s Sarcoma family of tumors (website)
  • Development of a plectin-1 targeted payload delivery system for treating pancreat (website)
  • Development of a Urine Test for the Early Detection of Liver Cancer (website)
  • Development of Novel Agents Targeting Genome Stability and Maintenance for Treati (website)
  • Development of Novel Drugs to Alleviate CPT-11 Toxicity (website)
  • Development of novel small molecule drugs for the treatment of high risk B-ALL (website)
  • Development of novel thiobarbituric acid analogs for malignant brain tumors (website)
  • Development of sd-rxRNAs as Therapy for Retinoblastoma and Other Malignancies (website)
  • Development of Small Molecule Crm-1 Inhibitor for Pancreatic Cancer Therapy (website)
  • Development of transporter targeted platinum drugs for neuroblastoma (website)
  • Devices enabling improved light delivery for photodynamic therapy of oral cancer (website)
  • Diagnosis, Prognosis and Treatment of hRgr associated Hematopoietic Malignancies (website)
  • Diindolylmethane:Inhibition of lung squamous cell carcinoma by targeting Akt (website)
  • Directed Evolution of Peptide Inhibitors of Myc-Max Dimerization (PQ18) (website)
  • Discovering genomic rearrangements under selection in serious ovarian cancer (website)
  • Discovery and Optimization of AML Prognostic Biomarkers (website)
  • Discovery and Targeting of Apoptosis Resistance Mechanisms in High-Risk T-ALL (website)
  • Discovery of New Targets and Pathways for T-ALL Therapy (website)
  • Discovery Of Small Molecular Activators Of Nr4a Orphan Nuclear Receptors (website)
  • Dissecting the relationship between declining lymphoid progenitor fitness and agi (website)
  • Dissection and manipulation of RB function (website)
  • Dissection of a fundamental step in gene activation using the HTLV-1-encoded Tax (website)
  • DNA methylation markers for early detection of thyroid cancer (website)
  • DNA-PKcs Phosphorylation on Hematopoietic Stem Cells Genome Maintenance (website)
  • Do barriers to transplantation impact liver cancer survival in Asians? (website)
  • Dysregulation of mTORC2 in gliomas (website)
  • Early events of in vitro KSHV infection (website)
  • Early Life Exposures to Air Toxics and the Risk of Early Childhood Leukemia (website)
  • Effect of Beta-secretase Inhibitors on Pancreatic Cancer Cells (website)
  • Effect of exercise on cortisol dysregulation in ovarian cancer survivors (website)
  • Effect of high fat diet on pancreatic cancer in IKKa deficient mice (website)
  • Effect of Omega-3 Fatty Acids on Cancer Stem Cells (website)
  • Effectiveness of minocycline for reducing symptoms in pancreatic cancer patients (website)
  • Effects of Extravasated Serum Proteins on Human Glioblastoma Invasion (website)
  • Effects of short-chain fatty acids on Epstein-Barr virus in B cell lymphoma (website)
  • EGF receptor, DNA methylation and platinum resistance in ovarian cancer (website)
  • Elucidate and Modulate TGF-b Signaling in NK Cells for Glioma Treatment (website)
  • Elucidating p53 transcriptional networks involved in pancreatic cancer suppressio (website)
  • Elucidating the in vivo Role of the p53 Apoptosis-Specific Target Gene Siva (website)
  • Elucidating the role of TIN2L at the telomere and in dyskeratosis congenita (website)
  • Enabling NF-kB Signal Transduction Studies in Primary Multiple Myeloma Cells (website)
  • EndoPulse System for Endoscopic Ultrasound-Guided Therapy of Pancreatic Carcinoma (website)
  • Enhancing radiation and cisplatin HNSCC cell killing by inhibiting mitochondrial (website)
  • Enhancing tumor vascular damage with gold nanoparticles aided radiation therapy (website)
  • Epigenetic and clinical impact of SMARCB1 loss in cancer (website)
  • ETV4 in pancreatic cancer (website)
  • Evaluating the impact of KRas codon bias on pancreatic cancer (website)
  • Evaluation of a novel urothelial cancer biomarker of lethality (website)
  • Evaluation of In Vitro Companion Diagnostic Monoclonal Antibodies for Use in a St (website)
  • Evaluation of locally-delivered fenretinide and black raspberries for oral cancer (website)
  • Evaluation of Treatment Underreporting Using SEER-Medicare Data (website)
  • Evolution of cancer-specific molecular requirements for glioblastoma multiforme ( (website)
  • Examining role of splicing factor mutations in myelodysplastic syndrome (PQ11) (website)
  • Exocytic pathways in HNSCC progression (website)
  • Exploration of Activity of RAD001 in vivo in Vestibular Schwannomas and Meningiom (website)
  • Exploring the Association Between Immune-Related Genetic Variation and HNSCC (website)
  • Exploring the relationship of Vitamin D and childhood brain tumors (website)
  • Extracellular Sulfatases As Novel Biomarkers For Early Detection of Cancer (website)
  • Fanconi anemia pathway in DNA damage repair (website)
  • Fate-mapping temporally marked precursor populations to hepatocellular carcinoma (website)
  • FISH assay identifying oral cancer patients at low risk of lymph node metastasis (website)
  • Flavonoids, esophageal/gastric cardia adenocarcinoma and Barretts Esophagus Risk (website)
  • Four-Dimensional Mri For Image-Guided Radiation Therapy For Pancreatic Cancer (website)
  • Foxo transcription factors are required for maintenance of acute myeloid leukemia (website)
  • Function of ADAR1 in Hematopoietic and Leukemia Stem Cells (website)
  • Functional analysis of cIAP2-MATL1, MALT1 and proteolytic targets in B cells (website)
  • Functional analysis of leukemic CREBBP mutations (website)
  • Functionizing the epigenome in Ewing sarcoma (website)
  • Gadd45 stress sensors in leukemia (website)
  • Genetic and epigenetic basis of relapse in acute myeloid leukemia (website)
  • Genetic Risk Factors for Ewing’s Sarcoma (website)
  • Genetic Susceptibility and Biomarkers of Platinum-related Toxicities (website)
  • Genome-wide Identification of DNA Methylation Biomarkers in AML (website)
  • Genomic Discovery and Targeted Therapeutics in Squamous Cell Lung Cancer (website)
  • Genomics of Acute Myelogenous Leukemia (AML): Relapse and Resistance Factors (website)
  • Genomics of Acute myelogenous leukemia (AML): Whole Genome Resequencing (website)
  • Genomics of AML: Contribution of Cytokine Signaling Pathways to Leukemogenesis (website)
  • Genomics of Treatment -Related Acute Myelogenous Leukemia: Susceptibility Factors (website)
  • Germline Telomere Biology Defects in Pediatric and Young Adult Acute Myeloid Leuk (website)
  • Glioblastoma PDT Design: Nanoagent Uptake and Tumor Oxygenation based dosimetry (website)
  • Glycomics Laboratory for the Early Detection of Epithelial Ovarian Cancer (website)
  • GPCR regulation of progenitor cells in pancreatic cancer (website)
  • G-quadruplex in Translational Regulation and Cancer Therapy (website)
  • GSK3b mediates radiation-induced cytotoxicity in hippocampal neurons (website)
  • GUCY2C targeted adoptive T cell therapy to treat metastatic colorectal cancer (website)
  • HBx regulation of miRNA-mediated mRNA silencing in HCC development (website)
  • Hdac3 as a therapeutic target in BCL6-dependent lymphoma (website)
  • Head and Neck Cancer Risk Prediction Model (website)
  • Head and Neck squamous cell carcinoma radiation response modulation by HPV (website)
  • Hepatitis B virus X protein modulation of calcium signaling in HCC development (website)
  • Hepatocyte Nox proteins in the pathogenesis of hepatocellular carcinoma (website)
  • Homogeneous Nanoparticle-Based Assays for Protease Detection (website)
  • Humanized Anti-Trop2-SN-38 Conjugate For Advanced Pancreatic Cancer (website)
  • HVEM-BTLA Pathway in Lymphoma (website)
  • Hypoxia Image-Guided Radiation Therapy (website)
  • Hypoxia-induced Metabolic Changes in Cancer (website)
  • Identification of regulatory cancer risk SNPs for chemoprevention discovery (website)
  • Identification of the protein homeostasis network that controls the quality contr (website)
  • Identifying Cancer Health Communication Channels for Hispanic Audiences (website)
  • Identifying Familial Pancreatic Cancer Predisposition Genes (website)
  • Identifying rare haplotype-environment interactions using Logistic Bayesian Lasso (website)
  • Identifying underlying mechanisms of intracellular changes in response to caregiv (website)
  • IGF1R: A candidate oncogene in pediatric high grade gliomas (website)
  • IKKalpha, autophagy, obesity and injury enhanced pancreatic cancer (website)
  • IL-15 Superagonist Complex as an Immunotherapeutic for Multiple Myeloma (website)
  • Image Guided Immuno Therapy For Inducible Antigens (website)
  • Image-guided thermo-chemoembolization for treatment of liver cancer (website)
  • Imaging T Cells By Positron Emission Tomography (website)
  • Immune Evasion by Multiple Myeloma: Role of the Rho Kinase Signaling Pathway (website)
  • Immune Modulation by Gammaherpesviruses (website)
  • Immunobiology and immunotherapy of pancreatic cancer (website)
  • Immunotransplant to Mantle Cell Lymphoma: Immune Response and Clinical Outcomes (website)
  • Impact of genetic variation on response to GO therapy in COG-AML clinical trials (website)
  • Impact of Radiation on Stem Cell Maintenance and Leukemogenesis (website)
  • Improved therapeutic approaches for hematological disorder treated with tyrosine (website)
  • Improving Rectal Cancer Surgery Through Regional Collaboration (website)
  • Improving therapy of glioblastoma multiforme by enhancing therapeutic drug delive (website)
  • In vivo detection of involvement of endogenous BM progenitor cells in glioma (website)
  • In Vivo Metabolic Catastrophe Is Induced By Acute Oncogene Inhibition (PQ #22) (website)
  • Ind 20212 (03-25-99) Phase 2: Orbec (Oral Bdp)-Patients With Chronic GVHD (website)
  • Inefficient autophagy, mitochondrial dysfunction, and pancreatic tumorigenesis (website)
  • Inhibiting glioma dispersal using non-toxic, natural products (website)
  • Inhibition of Autophagy Enhances Anti-Angiogenic Efficacy in Intracranial Glioma (website)
  • Inhibition of Reflux-Induced Esophageal Adenocarcinoma by Proanthocyanidins (website)
  • In-situ Gelling Protein Polymer Intravascular Embolic Agent for Hepatic Carcinoma (website)
  • Integrating plasma IGF-1 into novel classification of hepatocellular carcinoma (website)
  • Integrative Cancer Genomics: Drivers, Pathways and Drugs (website)
  • Integrin Targeted Therapy for the Treatment of Ovarian Cancer (website)
  • Interactions of the angiopoietin and PD-ECGF pathways in tumor angiogenesis (website)
  • International Registry of Werner Syndrome (website)
  • Interplay of Tumor Microenvironment and MUC4 in Pancreatic Cancer (website)
  • Investigating Cancer Stem Cells – Niche Interactions in Brain Tumor (website)
  • KillerRed Assisted Mutagenesis to discover cancer drug resistance genes (website)
  • Ki-Ras Signaling in Pancreatic Cancer: Role of a Novel Akt Regulator (website)
  • Lay Health Worker Model to Reduce Liver Cancer Disparities in Asian Americans (website)
  • Light-targeted drug delivery (website)
  • Linking tumor chemoresistance to TLR variants that mediate damage chain reaction (website)
  • Lipogenic inhibitors in prevention of oncogene induced liver cancer (website)
  • Live Cell Interferometry for Quantifying Mass Transport in Cancer (website)
  • LRH-1: Structure-based Approach to Drug Design for Gastrointestinal Tumors (website)
  • Magnetic-vortex microdiscs for glioma therapy (website)
  • MAP Kinase Signaling in Lymphoma: A Novel Therapeutic Paradigm (website)
  • Massively Parallel Sequencing for Familial Colon Cancer Genes (website)
  • Mcl-1 in apoptosis and signal transduction: a structure/function approach (website)
  • Measles Virotherapy for Multiple Myeloma (website)
  • Mechanism of chemopreventive synergism from the combination of EGCG and Erlotinib (website)
  • Mechanisms by which Oncogene Inactivation Elicits Tumor Cell Death (website)
  • Mechanisms of Anticancer Agents Selective against Drug Resistant Leukemia (website)
  • Mechanisms of Metabolic Gene Mutations in Cancer (website)
  • Mechanisms of Pancreatic Tumor Nerve Invasion (website)
  • Mechanisms of resistance to clinically-effective FLT3 kinase inhibitors in AML (website)
  • Mechanisms promoting translocations and mature B cell lymphomas (website)
  • Mechanistic Studies of MUC4 and NGAL in Pancreatic Adenocarcinoma (website)
  • Mesothelin as a biomarker for clinical management of esophageal adenocarcinoma (website)
  • Metabolic contribution to cell viability and therapy resistance in the acute (website)
  • Metabolic control of hepatocellular carcinoma by PGC1alpha (website)
  • Metabolic Reprogramming: Essential Role and Early Marker of MGUS Progression (website)
  • Metastatic protein network in BRAFV600E positive human thyroid cancers (website)
  • miRNA Biomarkers for Hepatocellular Carcinoma Associated with Viral Hepatitis (website)
  • Mitochondrial DNA and Ovarian Cancer Risk and Survival (website)
  • Mitochondrial Homeostasis in Metabolically Distinct Subsets of B-Cell Lymphoma (website)
  • Modelling the Growth of the MIC Niche at the System Level (website)
  • Models for Consortium Level Analysis of GxE Interaction in Complex Disease (website)
  • Modulation of Oncogenic Signaling in Glioblastomas (website)
  • Modulation of Radiation-induced Brain Injury in the Nonhuman Primate (website)
  • Modulation of the mTOR Pathway for Lung Cancer Treatment (website)
  • Molecular analysis of the function of BRCA1-TONSL complexes (website)
  • Molecular and cellular mechanisms of Merkel Cell Carcinoma development (website)
  • Molecular Basis for Localization and Activation of Focal Adhesion Kinase (website)
  • Molecular Basis of Autophagy and Its Role in Cancer (website)
  • Molecular epidemiology of non-Hodgkin lymphoma prognosis and prevention (website)
  • Molecular Mechanism of Orlistat Hydrolysis by FASN for Targeted Drug Discovery (website)
  • Molecular mechanisms of B cell malignant transformation (website)
  • Molecular mediators of tumor suppression for the PTPRD phosphatase in gliomas (website)
  • Molecular Programs for Stem Cells of Hematological Malignancies (website)
  • Molecular Targeted Therapy for Retinoblastoma (website)
  • MR Imaging of IDH Mutational Status in Brain Tumors (website)
  • MUC1 and resistance of cancer cells to oncolytic virotherapy (website)
  • MUC1 Roles in ovarian cancer pathogenesis and immune therapy (website)
  • Multiplexed Single-Cell Analysis of EGFR and HER2 Activity in Gastric Cancer Cell (website)
  • Murine Model of HCV-Associated Human Liver Cancer (website)
  • Mutation-Specific p53 Antibodies as Biomarkers of Pancreatic Cancer (website)
  • Myb, a key driver of pancreatic cancer progression and metastasis (website)
  • Myc-directed control of mRNA turnover in lymphopoiesis and lymphomagenesis (website)
  • MYCN-induced calcium and magnesium signaling regulates Neuroblastoma progression (website)
  • N-3 Fatty Acid-Induced Akt Suppression: Chemoprevention for Pancreatic Neoplasia (website)
  • Nanoscale proteomic profiles of hypoxia pathways to develop biomarkers of renal c (website)
  • Neural Stem Cell-Selective Drug Target for Small Molecule Therapy of Brain Tumors (website)
  • Neurocognitive and Family Functioning at End of Therapy in Pediatric Brain Tumor (website)
  • New ultra-selective kinase inhibitors for the treatment of AML (website)
  • Non-invasive sampling of DNA markers for pancreatic cancer screening (website)
  • Non-neoplastic cell types dictate gliomagenesis and (website)
  • Novel anti-ganglioside therapy (website)
  • Novel Biomarkers in Cutaneous T Cell Lymphoma (website)
  • Novel Hedgehog Receptors as Therapeutic Targets In Pancreatic Cancer (website)
  • Novel Immunotherapies for Lymphoid Malignancies (website)
  • Novel L-threo-sphinganines for ceramides-based cancer therapy (website)
  • Novel Mechanism for Myc-Induced Apoptosis (website)
  • Novel Pathogen Associated Cancers (PQ12) (website)
  • Novel SET Antagonists for the Treatment of Chronic Myelogenous Leukemia (website)
  • Nuclear receptor LRH-1 in pancreatic cancer (website)
  • Objective decision support environment for clinical trials (website)
  • Omega-3 Fatty Acid Effects on Pancreatitis and Adenocarcinoma Development (website)
  • Oncogene Cooperativity in Leukemia Stem Cells (website)
  • Online Problem-Solving Skills Training for Mothers of Childhood Cancer Patients (website)
  • Onset and biomarkers for progression of monoclonal gammopathies (website)
  • OPPC targeting to improve pancreatic cancer treatment (website)
  • Optimizing Therapeutic Index of mAb-IFN_alpha Molecule to Treat Lymphoma (website)
  • Osteosarcoma Translational Research (website)
  • Other functions – a novel pet probe for use in cancer diagnostics (website)
  • Other functions r&d- biomedical (basic research) (website)
  • Other functions sbir phase ii topic 275, generic erbitux for treatment of egfr+ (website)
  • Other functions scalable automated brain tumor segmentation (website)
  • Other functions tas: 750849 reformulation of cancer therapeutics using nanotech (website)
  • Other functions topic 277, developing bh3 profiling as a companion diagnostic fo (website)
  • Ovarian Cancer Initiating Cells: Metabolic Characterization (website)
  • Ovarian Cancer: Prevention of the Disease and Its Recurrence (website)
  • Pancreas cancer combination therapy based on stromal modulators and nano-carriers (website)
  • Parental age at birth and risk of adult-onset cancer in female offspring (website)
  • Patient Oriented Research Program in Neuro-oncology (website)
  • Patterns of Care (POC) Quality of Care Dx Yr 2011 (website)
  • PDAC-on-a-Chip for Selection of Aggressive, Therapy-Resistant Tumor Cells (website)
  • Peptide-targeted alpha-particle emitting phage for ovarian cancer therapy (website)
  • Peripheral blood biopsy for molecular diagnosis of pancreatic cancer (website)
  • PET Enabled Microspheres for Radioembolization of Liver Tumors (website)
  • PFK-015: An inhibitor of PFKFB3 to treat Glioblastomas (website)
  • Phenotype-Genotype Associations with Symptoms During Childhood Leukemia Treatment (website)
  • PhScN as a Potent Agent for Use with Radiation in Pancreatic Cancer (website)
  • PKCz;a novel therapeutic target for pancreatic cancer ‘stem cells’ (website)
  • Polyvalent siRNA-Gold Nanoparticle Constructs to Eradicate Glioma (website)
  • Post GWA Studies in Testicular Germ Cell Tumors (website)
  • Potent organometallic inhibitors of Signal Transducer and Activator of Transcript (website)
  • Predicting toxicity and success of anti-GD2 immunotherapy of neuroblastoma (website)
  • Prevention of EtOH-induced promotion of hepatocarcinogenesis by genistein/soy (website)
  • Prime/Boost Vaccine to Prevent Hepatocellular Carcinoma (website)
  • Prognostic and Functional Significance of Adhesion Molecules in Pediatric AML (website)
  • Prospective Study of Serum MIS and Gynecologic Cancer Risk (website)
  • Protectan CBLB502 for the improvement of head and neck cancer radiation therapy (website)
  • Protein Biomarkers in Childhood Acute Myeloid Leukemia (website)
  • Psychological stress, associate biologic mediators, and ovarian cancer risk (website)
  • Quantitative and Spatial Optimization for Designing Cancer Therapeutics (website)
  • Radiotherapy as Immunotherapy of Tumors (website)
  • Rare Cancer Genetics Registry (website)
  • Rapid Testing of Drug-Resistant BCR-ABL(+)Leukemia Cells (website)
  • Real-time prediction of thermal ablation-induced cell death by echo decorrelation (website)
  • Regulation of Pre-mRNA Splicing in Tumorigenesis (website)
  • Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma (website)
  • Regulators of Cancer-Specific DNA Hypermethylation (website)
  • Replication Profiling as a Diagnostic Tool in B-cell Acute Lymphoblastic Leukemia (website)
  • Resequencing (website)
  • Resonance Imaging Trial for Heart bioMarkers (RITHM) in AYA Cancer Survivors (website)
  • Response To Therapy For Patients With Glioma Using Hyperpolarized C-13 Pyruvate (website)
  • Retroviral replicating vector for prodrug activator gene therapy (website)
  • Reverse ChIP: Sequence-specific extraction of DNA-bound histones for analysis of (website)
  • Reversing genetically modified T cell suppression in a model of liver metastases (website)
  • RF-SRC: A Unified Data Tool (website)
  • RIPK-dependent necrosis in development and cancer (website)
  • RNA from Brush Cytology to Identify Aggressive Squamous Cell Carcinoma (website)
  • Robotic Ultrasound Image Guidance System for Radiation Therapy (website)
  • Robust rank-based methods and detection of GXE in cancer etiology and survival (website)
  • Role of acetyltransferase gene inactivation in follicular lymphoma pathogenesis (website)
  • Role of Ascl1 in glioma (website)
  • Role of cell cycle withdrawal in restricting pancreatic cancer progression (website)
  • Role of Collaborator Proteins in Hoxa9-Mediated Leukemogenesis (website)
  • Role of EZH2 in Epithelial Ovarian Cancer (website)
  • Role of HSF1 in B cell activation and lymphoma (website)
  • Role of Kallikrein 6 expression and secretion in colon cancer (website)
  • Role of liver fluke granulin in cholangiocarcinogenesis (website)
  • Role of microRNAs in the regulation of CML stem cell survival and self renewal (website)
  • Role of miRNA-375 in Invasive Phenotype of Head and Neck Squamous Cell Carcinoma (website)
  • Role of NIAM, A Putative Cancer Gene, in Chromosomal Instability and Gliobastoma (website)
  • Role of PGDH in leukemia pathogenesis (website)
  • Role of PLGF in Medulloblastoma Progression and Treatment (website)
  • Role of Reishi on cell surface proteins and signaling modulation in IBC (website)
  • Role of TET proteins in myeloid malignancies (website)
  • Role of TTK/Mps-1 upregulation by Ral GTPase activation in pancreatic oncogenesis (website)
  • Roles of MiR-17-92 Cluster MicroRNAs in K-Ras-Induced Pancreatic Tumorigenesis (website)
  • ROR1 as a Therapeutic Target in Acute Lymphoblastic Leukemia (website)
  • Screening and Risk Biomarkers for Ovarian Cancer in EPIC Specimens (website)
  • Selective Differentiation of Glioblastoma Stem Cells (website)
  • Selective Sensitization of Pancreatic Cancer to Therapy by Chk1 and PARP1 Inhibit (website)
  • Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach (website)
  • Sigma-2/Peptidomimetic Conjugates Target Apoptosis In Pancreatic Cancer (website)
  • Signal processing for accurate detection of copy number variants in cancer (website)
  • Signaling Networks in Glioblastoma Drug Resistance (website)
  • Simultaneous attack of epithelial and stromal compartments in pancreatic cancer (website)
  • Single Cell Analysis of Sphingosine Kinase Activity in Human Leukemia Stem Cells (website)
  • Southern Oncology Network on Adverse Reactions (SONAR) – Focus on Tyrosine Kinase (website)
  • Specimen Acquistition and Expression Profiling (website)
  • Sphingosine-1-Phosphate Pathway Based Therapy for Neuroblastoma (website)
  • Squamous Cell Carcinoma of the Lung: Validation of Molecular Signatures for Progn (website)
  • Staging of upper tract urothelial cancer with optical coherence tomography (website)
  • Stat3 Signaling in Pancreas Cancer (website)
  • Statistical Strategies for Establishing Etiologic Heterogeneity of Tumors (website)
  • Steroid Receptor Coactivator-2 as a key hepatic tumor suppressor and circadian me (website)
  • Strategies to Improve Kaposi’s Sarcoma Outcomes in Zimbabwe (website)
  • Structural mutation analysis of PTEN and its possible genotype-phenotype correlat (website)
  • Studies of Lymphoma Suppression and DNA Repair (website)
  • Study of Anti-Survival signals in NF1 (website)
  • Super-infection and virus spread during chronic hepadnaviral infection (website)
  • Susceptibility Markers for a Breast-Colon Cancer Phenotype (website)
  • Suv39H Targeted Therapy for Treatment of Childhood Rhabdomyosarcoma (website)
  • Synergistic innate immune activation and cell killing by RIG-I ligands in HCV-HCC (website)
  • Systematic Development of Novel, Druggable Cancer Targets (website)
  • Systems Biology of Tumor Progression and Drug Resistance (website)
  • Targeted Glycomics and Affinity Reagents for Cancer Biomarker Development (website)
  • Targeting a new GPCR to treat glioblastomas (website)
  • Targeting a non-canonical RAS-driven pathway in pancreatic cancer (website)
  • Targeting Akt with substrate mimetic antagonists (website)
  • Targeting an ATM-dependent metabolic pathway and FLT3 for AML therapy (website)
  • Targeting CD44 in the bone marrow microenvironment of MM (website)
  • Targeting c-MYC Overcomes Temsirolimus and Cisplatin Resistance of Ovarian Cancer (website)
  • Targeting Focal Adhesion Kinase in Thyroid Cancer (website)
  • Targeting HMGB1-mediated Autophagy in Cancer Therapy (website)
  • Targeting Kinases that Phosphorylate the KSHV LANA Chromatin Binding Domain (website)
  • Targeting Leukemia Stem Cells with Dietary Selenium (website)
  • Targeting MUC1-induced Tumor-stromal Metabolic Cross-talk in Pancreatic Cancer (website)
  • Targeting MUC4 for chemosensitization of pancreatic cancer (website)
  • Targeting non-classical oncogenes as therapy for T-ALL (website)
  • Targeting Ovarian Tumor Associated Myeloid Cells with Nanoparticles Therapeutics (website)
  • Targeting p300 and lysine acetylation in AML (website)
  • Targeting Plasmacytoid Dendritic Cells to Treat Human Myeloma (website)
  • Targeting Slc16a/Mct Lactate Transporters in Cancer Therapeutics (website)
  • Targeting the aberrant kinome-epigenome in AML (website)
  • Targeting the B Cell Receptor Signaling Network in Lymphoma (website)
  • Targeting the ERCC1/XPF nuclease for cancer therapy (website)
  • Targeting the JAK/STAT-3 Pathway Signaling Axis in Glioma (website)
  • Targeting the let-7-HMGA2 Network in Metastatic Progression in Pancreatic Cancer (website)
  • Targeting to Epigenetic Modications in ALL (website)
  • Targeting Tumorigenic Pathways in Glioblastoma with Oncolytic HSV (website)
  • Temporal and Spatial Control of V(D)J Recombination (website)
  • Testing of novel anti-cancer compounds Curaxins against pancreatic cancer (website)
  • Th1/Th17 Macrophage Interactions in Cutaneous GVHD (website)
  • The anti-senescence activity of trefoil factor 1 (website)
  • The Basic and Translational Implication of SIRT1 and DNMT1 in Cancer (website)
  • The effects of dexamethasone on tumor and microglial cells in glioma (website)
  • The Function of rpL5 and rpL11 in induction of p53 (website)
  • The Functional Analysis of Ovarian Cancer Susceptibility Locus 9p22.2 (website)
  • The Impact of Hspa9 Haploinsufficiency on Murine Hematopoiesis and Leukemogenesis (website)
  • The interaction of Burkitt’s lymphoma cofactors EBV and Plasmodium (website)
  • The Requirement for Trib2 in the Maintenance of Acute Myeloid Leukemia (website)
  • The role of a histone H4 phosphorylation in drug resistance (website)
  • The role of AF10 in normal and leukemic hematopoiesis (website)
  • The Role of Eya3 as a downstream target of EWS Fli1 in Ewings Sarcoma (website)
  • The role of fusion protein, OTT-MKL1, in acute megakaryoblastic leukemia (website)
  • The role of gremlin in regulating the differentiation of glioma stem cells (website)
  • The role of Hedgehog/Gli in normal hematopoiesis and leukemia (website)
  • The Role of IKK and NF-kappaB in Controlling mTOR Signaling and TSC Progression (website)
  • The Role of KIR and FcR Genotype in the Efficacy of mAb and IL2 Immunotherapy (website)
  • The role of mitogen-activated protein kinase phosphatase-1 in tumor progression (website)
  • The Role of NF-kB in B-Cell Differentiation and Lymphomagenesis (website)
  • The Role of NPM-ALK Signaling in Tumor Cell Metabolism (website)
  • The role of pRb-dependent Ihh in osteogenesis and osteosarcoma (website)
  • The Role of Stroma-derived Soluble TbetaRIII in Neuroblastoma (website)
  • The Role of Telomere Shortening in MDS-AML Pathogenesis (resubmission) (website)
  • The Roles of Microglia and Macrophage Populations in the Glioma Microenvironment (website)
  • The Roles of MicroRNAs in Glioblastoma (website)
  • The Roles of Tumor Microenvironment in Neurofibroma Development and Therapeutics (website)
  • Therapeutic Targeting of Novel Antifolates to Solid Tumors via Folate Receptor (website)
  • Tissue Factor splicing and pancreatic tumor progression: pilot studies (website)
  • Tissue-specific Roles of Axin in Canonical Wnt Signaling and Tumorigenesis (website)
  • TOR kinase inhibitors for leukemia therapy: mechanisms of action and resistance (website)
  • Toxicity Monitoring on Phase III Trials with Administrative Data (website)
  • Triptolide Augments Death Receptor Mediated Apoptosis in Pancreatic Cancer (website)
  • TSPO Ligands for Cancer Imaging (website)
  • Tumor-targeted anti-CK2 RNAi for treatment of HCC (website)
  • Ultrasound-assisted convection-enhanced drug delivery to the brain (website)
  • Understanding Mechanisms of Resistance to Anti-angiogenic Treatments (website)
  • Understanding the role of SKP2 in small cell lung cancer progression (website)
  • Unusual Evolutionary Patterns in BRCA1 and their Implications for Cancer (website)
  • Use of Allogenicity to Stimulate Effector Responses Against Multiple Myeloma (website)
  • Utilizing proteoglycan biology to develop a novel treatment for brain cancers (website)
  • Vaccine Immunotoxin and Radioimmunotherapy of Primary and Metastatic CNS Tumors (website)
  • Validation of a risk model for stage I lung adenocarcinoma (website)
  • Validation of PROMIS Measures in Children with Brain Tumors (website)
  • Vascular mechanisms regulating breast cancer brain metastasis (website)
  • Vitamin D and Non-Hodgkin Lymphoma Prognosis (website)
  • Whole Genome Sequencing to Discover Familial Myeloma Risk Genes (website)
  • XBP1s and Resveratrol regulate the BMSCs’support of myeloma growth and osteoclast (website)
  • Xenograft Model to Study Impact of CRLF2-Ligand in Hispanic Childhood B-ALL (website)
  • ZNF-Mediated Resistance to Imatinib Mesylate in Gastrointestinal Stromal Tumor (website)

2011

  • 124I-cG250 ImmunoPET Imaging of Sunitinib Treatment Response in Renal Cell Cancer (website)
  • A causal role for asymmetric cell division defects in glioma initiation (website)
  • A FAP-Activated Proteasome Inhibitor for Killing Solid Tumors (website)
  • A Fourth Outcome: DNA Damage and the Differentiation of B Cells (website)
  • A genome-wide methylation study of epigenetic contributions to multiple myeloma (website)
  • A new small molecule targeting agent and therapeutic for non-Hodgkin’s lymphoma (website)
  • A novel approach to target Rb mutant cancers (website)
  • A novel combination therapy for the treatment of Pancreatic adenocarcinoma (website)
  • A Novel Modulator of Notch in Acute Lymphoblastic Leukemia (website)
  • A Phase I trial combining fenretinide and safingol to target overproduction of di (website)
  • A Phase II proof-of-concept trial to study kinase inhibition in relapsed/refracto (website)
  • A Pilot Study of Decitabine and Vorinostat with Chemotherapy for Relapsed ALL (website)
  • A prospective analysis of peripheral blood cytokines and non-Hodgkin lymphoma (website)
  • A Web-based Multimedia Intervention for Head and Neck Cancer Patients (website)
  • Aberrant activation of HGF/MET signaling as a therapeutic target in AML (website)
  • Aberrant DNA Methylation of MicroRNA Genes in Hepatocellular Carcinoma (HCC) (website)
  • Aberrant Glycosylation Signature in Pancreatic Cancer (website)
  • Acidic Phospholipid-Selective Treatment for Neuroblastoma (website)
  • Adherence to Cancer Risk Management Among Unaffected BRCA1/2Mutation Carriers (website)
  • Advanced Development of a Multiplexed SERS-based Biomarker Detection Platform: A (website)
  • Allogeneic B Cell Responses (website)
  • Allogeneic HCT for Hematologic Malignancies: Immune Manipulations (website)
  • Allogeneic HCT for Hematologic Malignancies: Pharmacologic Manipulations (website)
  • Allogeneic stem cell transplant with grafts depleted of naive T cells for leukemi (website)
  • Allografting for Lukemia (website)
  • Altered cellular bioenergetics influences NKT cell mediated responses to Lymphoma (website)
  • Altered Glycolytic Pathway in in vitro Models of leukemia developed in hypoxia (website)
  • Anthrax Toxin Receptor as a marker and target of breast cancer stem cells (website)
  • Anti-beta2 microglobulin as a novel therapeutic agent in multiple myeloma (website)
  • Antibody bead array technology for diagnosis of pre-invasive pancreatic cancer (website)
  • Antibody-interferon fusion proteins for treatment of B-cell malignancies (website)
  • Anti-CTLA-4 enhances the effects of imatinib in gastrointestinal stromal tumor (website)
  • Apparatus and Method for Convection Enhanced Therapeutic Delivery (website)
  • Application of Boolean Networks to discover stem and progenitor cells (website)
  • Approaches to discover and quantify apoptotic biomarkers for cancer treatment (website)
  • Array Microscope Assay for Cancer Cell Mechanics (website)
  • Assisted Reproductive Technology & Risk of Childhood Cancer (website)
  • Asymmetric Total Synthesis of Vindoline and Novel Analogues (website)
  • Atm, Reactive Oxygen, And Cellular Responses To Hypoxia (website)
  • Autografting for Lymphoma (website)
  • Autophagy and apoptosis in the response of c-KIT cancers to targeted therapy (website)
  • Backbone Degradable Polymer-drug Conjugates for the Treatment of Ovarian Cancer (website)
  • Barrett’s Esophagus Translational Research Network Coordinating Center (website)
  • Barriers to Early Detection of Esophageal Adenocarcinoma (website)
  • Bilateral oophorectomy and cancer risk and mortality in African American women (website)
  • Bioactive compound modulation of epigenetic regulator Sp1/NFkB/miR network in AML (website)
  • Biobehavioral Mechanisms Facilitating Recovery From Stem Cell Transplantation (website)
  • Biomarker(s) for the diagnosis of pancreatic cancer (website)
  • Biomarkers of Opisthorchis viverrini-induced cholangiocarcinoma (website)
  • Biophotonics Noninvasive Detection of Ovarian Cancer (website)
  • Biophysical and molecular dialogue of glioma cells and the brain microenvironment (website)
  • Biosensor technology to monitor leukemia-related kinase activity in patient cells (website)
  • Blood Cell-Spheres: Growth, Description, and Potential (website)
  • Bone Marrow Micrometastatic Disease in Ewing Sarcoma (website)
  • BRIT1, a novel hepatocellular carcinoma tumor suppressor (website)
  • Cancer Risk in Pediatric-Onset Rheumatic Disease (website)
  • Cancer Stem Cell Niche in Brain Tumors (website)
  • Cancer Stem Cells in Acute Lymphoblastic Leukemia and Ovarian Carcinoma (website)
  • Carboxylesterase-activated Doxazolidine-prodrug for Hepatocellular Carcinoma (website)
  • Cardiac Sparing Whole Lung IMRT in Children and Young Adults with Lung Metastases (website)
  • Case GI SPORE (website)
  • CB: Pancreatic Tumor SPORE Tissue Bank (website)
  • CD38 Pretargeted Radioimmunotherapy for Myeloma (website)
  • CD4+ T cells in Invasive Aspergillosis (website)
  • CD40 Pathway in Pancreatic Adenocarcinoma (website)
  • CED of Nanoparticles Loading with Novel Agents for Improved Treatment of Gliomas (website)
  • Cell Processing and Sample Distribution (website)
  • Cellular and Genetic Basis of Anaplastic Medulloblastoma (website)
  • Cellular diversity and clinical relevance of stem cells in pancreatic cancer (website)
  • Cellular Imaging and Molecular Pathology (website)
  • Cellular Predisposition to Retinoblastoma Tumorigenesis (website)
  • Cellular Response to Short Telomeres in B-Cell Lymphoma (website)
  • Center for Environment-Mediated Drug Resistance in Pediatric Cancer (website)
  • Characteristics of tubal ligation and risk of epithelial ovarian cancer (website)
  • Characterization of Myeloid Tumor Suppressor Genes on Chromosome 5 (website)
  • Characterization of the Multiple Myeloma Cancer Stem Cell and its Niche (website)
  • Characterizing a New Human Dendritic Cell Lineage and Its Role in LCH (website)
  • Characterizing Notch3 Signaling in Ovarian Cancer (website)
  • Chemical Inhibitors of Rhabdomyosarcoma Self-Renawal (website)
  • Chemoprevention of pancreatic cancer using a combinatorial nano-drug system (website)
  • Chemoprevention of Peutz-Jeghers Polyposis in a Mouse Model by Niclosamide (website)
  • Chemoprotectants for Head-Neck Therapeutics (website)
  • Clinical Production and IND enabling Studies for PSCA Minibody Imaging in Pancrea (website)
  • Clinical Trails In Myeloid Maliganancies With Molecularly Targeted Therapies (website)
  • Clinical Translation of Deformation Compensation for Image-Guided Liver Surgery (website)
  • Clinically-Relevant Regulatory Networks in the Lung Tumor Microenvironment (website)
  • Communication Skills Intervention to Promote Transition into Survivorship (website)
  • Comparative gene resequencing in mouse cancer models (website)
  • Complementary Signaling Pathways In Hodgkin Lymphoma and Related Malignancies (website)
  • Conditional ablation of stellate cells to determine their role in pancreatitis an (website)
  • Conformal Total Body and Marrow Irradiation for Leukemia (website)
  • Contemporary Therapeutics For Anaplastic Gliomas (website)
  • Control of GVHD with Retained GVT (website)
  • Co-registered photoacoustic and ultrasound imaging for non-invasive ovarian can (website)
  • CPE Peptide-Based Nanoparticles for the Diagnosis and Therapy of Chemotherapy Res (website)
  • CpG-siRNA Conjugates to Target Acute Myeloid Leukemia (website)
  • CT Volume Measurement of Lung Cancer treated with Erlotinib: Genomic Correlation (website)
  • Design of Degron-based Substrates Capable of E3 Ligase-mediated Ubiquitination (website)
  • Determinants of late cardiovascular morbidity among survivors of hematopoietic ce (website)
  • Determining the clinical significance of monoclonal gammopathy of undetermined si (website)
  • Develop and Characterize a Novel Animal Model of Pancreatic Cancer (website)
  • Developing a Platform for Prediction of Metastasis Using Multiplexed QD-imaging (website)
  • Developing a plectin-1 targeted imaging agent for the detection of pancreatic can (website)
  • Development and Application of Novel Glycan-Specific Reagents to Facilitate Early (website)
  • Development Of A Rapid In Vitro Screening Assay For Detection Of Cancer Biomarke (website)
  • Development of Agents for Optimization of Photodynamic Therapy and Tumor Imaging (website)
  • Development of aptamer-based detection and therapy strategies for ovarian cancer (website)
  • Development of Clinical Strategies to Prevent GBM Recurrences After Radiotherapy (website)
  • Development of dihydroartemisinin as a novel preventive agent for prostate cancer (website)
  • Development of novel anti-leukemia agents targeting the menin-MLL interaction (website)
  • Dietary Prevention of Obesity-Enhanced Liver Cancer (website)
  • Disclosing Genomic Incidental Findings in a Cancer Biobank: An ELSI Experiment (website)
  • Discovery and Validation of Tumor Immunoevasion Mechanisms (website)
  • Dissecting Hedgehog, TGF beta and BMP Signaling During Pancreatic Tumorigenesis (website)
  • Dissecting the Role of Src Family Kinases in Breast Cancer Brain Metastasis (website)
  • DNA Polymerase Beta and Gastric Cancer (website)
  • DNMT3A mutations in acute myeloid leukemia (website)
  • Dual LSD1 and HDAC Inhibition for Cancer Therapy (website)
  • Dual Targeting of MEK and EGFR Signaling Pathways in Advanced Pancreatic Cancer (website)
  • EBV Specific T-cells from 3rd party donors for treatment of EBV-associated malign (website)
  • Ecd as a regulator of cell cycle and breast oncogenesis (website)
  • Elucidating the function of the widely inactivated phosphatase PTPRD in the molec (website)
  • Elucidating the role of NF-kB signaling in rhabdomyocarcoma (website)
  • Elucidating the Role of STAT3-Dependent Autophagy in Hepatocellular Carcinoma (website)
  • Elucidating the roles of ETV1 in the pathogenesis of GIST (website)
  • Endocrine Targets for Prevention of Lung Cancer (website)
  • Engineering and Evaluation of Human L-Methionase for Cancer Therapy (website)
  • Enhancing Treg Immune Reconstitution After Stem Cell Transplant (website)
  • Enhancing Viral Oncolysis with Vasculostatin Gene Delivery (website)
  • Enzyme-delivery scaffold technology for targeted cancer killing (website)
  • Epidemiology of testicular cancer in the Utah population (website)
  • Epigenetic alterations underlying tumorigenic potential of Glioblastoma Cells (website)
  • Epigenetic Regulation Of Sex-dependent Liver Cancer (website)
  • Epigenetic therapy with 3-deazaneplanocin A and gemcitabine for pancreatic cancer (website)
  • Epigenomic Markers of HNSCC Survival Across Ethnic Groups (website)
  • Escape from gammaherpesvirus-induced mRNA destruction (website)
  • Established Investigator Award in Pediatric Cancer Epidemiology (website)
  • Exome-wide screening for common mutations in lymphoma (website)
  • Exploring the mechanism and function of somatic homolog pairing (website)
  • Exploring the role of the de-ubiquitinase UCH-L1 in B-cell malignancy (website)
  • Extension of Radiotherapy Research (website)
  • Ezh2 in MLL-AF9 mediated acute myeloid leukemia (website)
  • Fish oil for the prevention and treatment of ovarian cancer (website)
  • FitFab 4 Survivors (website)
  • Flt3: Role in Leukemia Stem Cells (website)
  • FLT-PET/CT for Therapy Monitoring of DLBCL (website)
  • Function and targeting of a stable transcription factor complex in leukemia (website)
  • Functional Analysis of the BAP1 Metastasis Suppressor Gene in Uveal Melanoma (website)
  • Functional Genomics and Molecular Imaging of Liver Disease and Cancer (website)
  • Genetic Basis of Signaling Heterogeneity in Human Follicular Lymphoma (website)
  • Genetic Determinants Of Barrett’s Esophagus And Esophageal Adenocarcinoma (website)
  • Genetic dissection and inhibitor targeting of Rac signaling in pancreatic cancer (website)
  • Genetic Mechanisms of Survivorship Disparities after Unrelated HCT (website)
  • Genetic Therapy for Fanconi Anemia (website)
  • Genetics of Rhabdomyosarcoma (website)
  • Genome-Wide Association Study of Childhood Leukemia by Hispanic Status (website)
  • Genomic Analysis to Gain Insights into Novel and Clinically Relevant Mol (website)
  • Genomics Core (website)
  • Guideline-based surveillance and treatment of hepatocellular carcinoma (website)
  • HCV Strain Variation and HCC (website)
  • HDAC Inhibitors Inspired by Natural Products (website)
  • Hedgehog Palmitoylation as a Novel Target for Inhibiting Pancreatic Cancer (website)
  • Helicobacter pylori subtypes, inflammation, and gastric cancer risk (website)
  • Heparanase regulation of osteolysis in multiple myeloma (website)
  • Hepatitis D virus genomic RNA in the etiology of liver cancer (website)
  • Heterocellular 3D ovarian tumor arrays for imaging and mechanistic combinations (website)
  • High resolution and single cell analyses of PanIN initiation and progression (website)
  • High Resolution Microendoscopy for the Detection of Esophageal Neoplasia (website)
  • High Throughput Transcriptome Sequencing for Systematic Detection of Recurrent Tr (website)
  • Histone methyltransferase EZH2 in liver pathophysiology and carcinogenesis (website)
  • Hodgkin’s Lymphoma Stem Cells (website)
  • Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation (website)
  • HSC Derived MDSC for the Prevention of GHVD Without Suppressing GvL (website)
  • HSP27: A modulator and therapeutic target of SPARC-induced glioma invasion (website)
  • Human Herpesvirus-8 Replication and Kaposi Sarcoma Response to Treatment (website)
  • Humoral and cellular immunity in polyomavirus-linked Merkel cell carcinoma (website)
  • Hypoxia and HIF in Sarcomagenesis (website)
  • Identification and Characterization of Gene Fusions in Lung Adenocarcinoma (website)
  • IDO2 Targeting for pancreatic cancer treatment (website)
  • IEX-1 as a potential biomarker for early detection of myelodysplastic syndromes (website)
  • Ikaros regulation: study on hemo-lymphopoiesis (website)
  • Ikaros-based epigenetic regulation of T cell leukemogenesis (website)
  • Imaging Biomarkers For Radiation-Induced Necrosis (website)
  • Imaging for Y90 Microscphere SIRT Planning (website)
  • Immunotherapy of Pancreatic Adenocarcinoma (website)
  • Impact of molecular phenotype on glioma metabolism and growth (website)
  • Improving Cord Blood Transplantation (website)
  • Improving etoposide treatment of Ewing’s sarcoma (website)
  • Improving Immune Reconstitution via Cytokine-Mediated Expansion of Transplanted (website)
  • In vivo detection of 2-hydroxyglutarate in gliomas by spectroscopic MRI (website)
  • In vivo functional characterization of Myelodysplasia/Myeloid Leukemia Factor (website)
  • In Vivo Selection of Aptamers Targeting Pancreatic Cancer (website)
  • Incorporation of Genomic Sequencing into Pediatric Cancer Care (website)
  • Infant and Toddler Brain Tumors (website)
  • Infectious origins of childhood leukemia (website)
  • Inflammation and Immunosuppression in Lung Cancer (website)
  • Inhibiting the Survival And Proliferation Of EBV-Associated Tumor Cells (website)
  • Inhibitors of N-cahedrin in the treatment of pancreatic cancer (website)
  • Inhibitors of telomerase in treatment of Pancreatic Adenocarcinoma (website)
  • Initiation and evolution of the ovarian cancer microenvironment (website)
  • Integrated Analysis of High Throughput Cancer Genomic Data (website)
  • Integrated Image-Guided Targeted Therapy for Refractory Ovarian Cancer (website)
  • Integrating Genetic Testing for Lynch Syndrome in a Managed Care Setting (website)
  • Integrative Oncogenomics of Multiple Myeloma (website)
  • Integrin Linked Kinase and Ovarian Cancer Metastasis (website)
  • Interplay between Intrinsic and extrinsic force and glioma pathogenesis (website)
  • Intra-tumoral Heterogeneity in Osteosarcoma: Tumorigenicity & Malignant Revision (website)
  • Invadopodia assembly in pancreatic tumor-associated fibroblasts (website)
  • Investigating the Role of Autophagy in Pancreatic Cancer Radiation Resistance (website)
  • Investigation Of The Roles Of Nuclear Receptor Fxr In Hepatocellular (website)
  • KiSS1 treatment of pancreatic adenocarcinoma (website)
  • Long-Term Follow-up Core (website)
  • Mammographic Breast Density and Ovarian Cancer (website)
  • Mapping Eloquent Cortex Using Resting State Cortical Physiology (website)
  • Markers and therapeutic strategies for overcoming chemoradiotherapy resistance (website)
  • MCM Helicase as a Novel Target for Pancreatic Cancer Treatment (website)
  • Measles Virotherapy and radiovirotherapy in the Treatment of recurrent gliomas (website)
  • Mechanism of Action of Retinoic Acid Using CD38 (website)
  • Mechanism of Radiation Mediated Clearance of HPV Positive Head and Neck Cancer (website)
  • Mechanism-based therapies for pancreatic cancer informed by stromal microrheology (website) 2013
  • Mechanisms of Hedgehog Target Gene Selection in Development and Cancer (website)
  • Mechanisms of Reactivation of Epstein-Barr Virus from Latency to Lytic Replicatio (website)
  • Mechanisms of stromal fibroblast activation in esophageal tumors (website)
  • Mechanisms of subtelomere recombination in telomerase deficient tumors (website)
  • Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer (website)
  • Mechanistic and Translational Studies of PR-104:A New Hypoxia Activated Cytotoxin (website)
  • Mechanistic validation of SCF E3 ligase as a cancer and radiosensitizing target (website)
  • Metabolic Regulators of Tumor Cell Growth (website)
  • Metabolic roles for Lin28-let-7 miRNA pathway in sarcoma tumorigenesis (website) 2012
  • Metabonomics Studies of Human Diseases (website)
  • Methylation and Hepatocellular Carcinoma Outcomes (website)
  • micro RNA TARGETING of normal & leukemia stem- progenitor cells (website)
  • Microenvironmental modulation as a result of glioma therapy (website)
  • Microenvironmental regulation of the cancer stem cell phenotype by integrin a6 (website)
  • MicroRNA in Acute Myeloid Leukemia (website)
  • Mixed-Ligand Targeting of a Nano-Pharmaceutical Against GBM Stem Cells (website)
  • MLL fusion genes in myeloid and lymphoid leukemias (website)
  • Mnk Pathways and IFN-responses in Malignant Cells (website)
  • Modeling, Synthesis, and Biological Evaluation of Potential RXT Selective Agonist (website)
  • Models to predict prognosis and benefit from adjuvant therapy in renal cell carci (website)
  • Modulation of In Vivo Tumor Oxygenation via Polymersome-encapsulated Myoglobin (website)
  • Modulation of miR-31 by dietary zinc deficiency in rat esophageal carcinogenesis (website)
  • Molecular Analysis of Ethnic Variations in Wilms’ Tumor (website)
  • Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML) (website)
  • Molecular determinants of breast cancer malignancy (website)
  • Molecular Diagnosis and Prognosis in Aggressive Lymphoma (website)
  • Molecular Epidemiology of Pediatric Germ Cell Tumors (website)
  • Molecular epidemiology/functional analysis of microRNAs in Non-Hodgkin’s lymphoma (website)
  • Molecular Evolution of Multifunctional DNA Nanoparticles (website)
  • Molecular mechanisms of GBM radioresistance and strategies for radiosensitization (website)
  • Molecular Mechanisms of Impaired DAN Damage Response in Leukemia Pathogenesis (website)
  • Molecular Pathogenesis of Monoclonal B Cell Lymphocytosis and CLL (website)
  • Molecular Pathology of t-AML (website)
  • Molecular signatures for outcome prediction and therapeutic targeting in All (website)
  • Molecular Targets in T Lineage Leukemia (website)
  • MR Metabolic Imaging of Response to Targeted Therapies in GBM (website)
  • MR-Guided Precision Tliermal Tfierapy of Retroperitoneal Tumors (website)
  • MRI Assessment of Tumor Perfusion, Permeability and Cellularity (website)
  • MRI Capable Receptor Targeted Drug Delivery for Pancreatic Cancer (website)
  • MTOR as a therapeutic target in pediatric solid tumors (website)
  • mTOR inhibition for generating memory T cells to enhance ovarian tumor immunity (website)
  • Multifunctional Peptides for (MRI) Imaging (website)
  • Multi-Modality Quantitiative Imaging for Evaluation of Response to Cancer Therapy (website)
  • Multipotential mesenchymal stem cell-like cells in pancreatic tumorigenesis (website)
  • Multi-Spectral Targeted Imaging for Early Detection of Cancer in Barrett’s Esopha (website)
  • Murine Models Of Myeloid Malignancies (website)
  • Myeloid Tumor Suppressor Gene Discovery from Chromosome Band 7q22 (website)
  • Myeloma stem cell targeting by liver x receptors (website)
  • Myofibroblasts in Gastrointestinal Cancers (website)
  • Nanocaged Metal Tags in Massively Multiplexed Leukemia Bioassay and Beyond (website)
  • Nanosensor device for the detection of H. Pylori and prevention of gastric cancer (website)
  • NcoA5, a unique nuclear receptor coactivator in hepatocarcinogenesis (website)
  • Neurocognitive Outcomes Following Proton Beam Radiation Therapy for Treatment of (website)
  • New Therapeutic Targets in AML (website)
  • Nicotine, nicotinic receptors and lung cancer (website)
  • Non-Cell Autonomous Functions of N-cadherin in KRas-driven Preneoplastic Lesions (website)
  • Non-invasive Biomarker Panels for Early Detection of Lung Squamous Cell Carcinoma (website)
  • Non-invasive Physiologic Predictors of Aggressiveness in Renal Cell Carcinoma (website)
  • Non-Myeloablative Host Conditioning that Protects Against GVHD (website)
  • Novel Combination Therapy Against Pancreatic Cancer (website)
  • Novel Dynamic Liver Imaging Method with Flexible Temporal and Spatial Resolution (website)
  • Novel Mcl-1 inhibitors for Pancreatic Cancer Therapy (website)
  • Novel melampomagnolide B-based prodrugs for the treatment of leukemia??? (website)
  • Novel MRI Vascular Biomarkers for the Detection of Tumor Invasion (website)
  • Novel myeloma stem cell markers for therapy (website)
  • Novel Single Domain Antibodies with Multivalency and Multispecificity (website)
  • Novel systemic therapy to improve clinical outcome in small cell lung cancer (website)
  • Novel targeted therapeutics for multiple myeloma (website)
  • Novel therapeutic inhibition of the Rac oncogene in pancreatic cancer (website)
  • Oncogenesis and myeloid transcription factors in AML (website)
  • Oncogenic cooperation restrained by a putative internal antagonist in miR-17-92 (website)
  • Optical Imaging of Chemotherapy for Brain Tumors (website)
  • Osteopontin & Tumor Progression in Head and Neck Cancers (website)
  • Ovarian Cancer PDT: Multi-intracellular targeting and Image-guided dosimetry (website)
  • Overcoming stromal barriers to therapeutics in pancreas cancer (website)
  • Oxygen as a master immunologic switch (website)
  • Pancreatic Cancer: Crocetin as a Novel Therapeutic Approach (website)
  • Pancreatic Juice Biomarker for Pancreatic Cancer (website)
  • Pancreatic Tumor Micro-environment Network (website)
  • Parental Occupational Pesticide Exposure Assessment and Childhood Leukemia Risk (website)
  • PARP Inhibition to Treat Triple-Negative Breast Cancer Brain Metastases (website)
  • Pathologic BIM Suppression & Pharmacologic BH3 Replacement in B-Cell Lymphoma (website)
  • Pathway Dependence on Tyrosine Kinase TYK2 in T-cell Acute Lymphoblastic Leukemia (website)
  • Pathway Specific Imaging in VHL Deficient Renal Cancer (website)
  • Patient Access, Data Management, Statistical Analysis, and Tissue Culture (website)
  • Patient sample repository and specialized flow cytometry (website)
  • Patient-specific predictive modeling that integrates advanced cancer imaging (website)
  • PDE4B and pharmacoethnicity of childhood leukemia (website)
  • Personal tumor neoantigens for immunity against chronic lymphocytic leukemia (website)
  • PET tumor and proliferation imaging via cationic amino acid transport (website)
  • PET/CT Imaging of Malignant Brain Tumors with 124I-NM404 (website)
  • Pharmacogenetics of Cyclophosphamide ADRs in (website)
  • Pharmacologic /Genetic Inhibition of XBP1 as Hypoxia Targeted Therapeutic Strateg (website)
  • Phase 1 of AR-42 in relapsed CLL, lymphoma, myeloma (website)
  • Phase I Study of Humanized 3F8 Monoclonal Antibody (Hu3F8) in Patients with High- (website)
  • Photoacoustic Microscopy Of Neovascularization In Renal Cancer Growth And Therapy (website)
  • Plasmid Replicons of Human Tumor Viruses (website)
  • PMLRARalpha and PML directly regulate Fas-mediated apoptosis in vivo (website)
  • Pooled genome-wide analysis of kidney cancer risk (website)
  • Post-translational regulation of MLL in leukemogenesis (website)
  • Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia (website)
  • Preclinical Development of iRGD for Pancreatic Cancer (website)
  • Preclinical Evaluation of PK2 Antagonists for Pancreatic Cancer (website)
  • Predictive biomarker development in lung cancer: ROS1 chromosomal rearrangements (website)
  • Predictors of clinical outcome after therapeutic vaccination in follicular lympho (website)
  • Preliminary Evaluation of FDG-PET with anti-IGF-1R Targeted Therapy in GISTs (website)
  • Preoperative Image Updating for Guidance During Brain Tumor Resection (website)
  • Pretherapy 124I-MIBG Dosimetry for Planning 131I-MIBG Neuroblastoma Therapy (website)
  • Prevention of Tumor Progression by a Novel Approach (website)
  • Prognostic Genetic Biomarkers for Secondary Leukemia (website)
  • Proliferation-promoting activities of pRB (website)
  • Prospective Oral HPV and Risk of Head and Neck Cancers (website)
  • Proteasome-mediated Degradation of Hematopoietic Progenitor Kinase 1 in Pancreati (website)
  • Protective Immunity Against Herpesvirus Infections (website)
  • Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers (website)
  • Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers (website)
  • Psychosexual Intervention for Gynecologic Cancer Patients (website)
  • PTPMT1 Regulates Cancer Cell Bioenergetics by Suppressing Oxidative Metabolism (website)
  • Quantitative MRI of Glioblastoma Response (website)
  • Quantitative MRI-Guided Nanoembolization for Liver Cancer (website)
  • Quantitative Volume and Density Response Assessment: Sarcoma and HCC as a Model (website)
  • Quiescent Tc17 programmed CD8 T cells and their role in graft versus host disease (website)
  • Racial Disparities, Survival & Secondary Debulking for Ovarian Cancer (website)
  • Rapid Analysis of Intraoperatively Acquired DTI for Identification of Key White M (website)
  • Rapid Label-Free Detection of Acute Promyelocytic Leukemia (website)
  • Rational combination of EGFR and Hedgehog inhibitors in head and neck cancer (website)
  • Reciprocal Sonic Hedgehog And Cxcr4 Interactions In Medulloblastoma (website)
  • Redefining Langerhans Cell Histiocytosis as a Myeloid Dysplasia and Identifying B (website)
  • Reduced Temperature Thermal Ablation for HCC and other Liver Tumors (website)
  • Reducing Complement Inhibition to Treat Leukemia and Lymphoma (website)
  • Regulation and function of the vascular niche in glioma recurrence (website)
  • Regulation of Asymmetric Cellular Division in Glioma Stem Cells (website)
  • Regulation of caspase 9 RNA splicing in NSCLC cancer (website)
  • Regulation of DNA replication fork progression by ATM kinase activity (website)
  • Regulation of Extracellular Matrix 1(ECM1) and its role in thyroid carcinogenesis (website)
  • Regulation of hematopoietic stem cell and progenitor cell proliferation by Runx1 (website)
  • Regulation of lipogenesis by lysophosphatidic acid in ovarian cancer (website)
  • Regulation of Lung Cancer Metastasis by miR-200 (website)
  • Regulation of Myc-Mediated Tumorigenesis (website)
  • Regulation of Osteosarcoma Metastasis by Notch and Hes 1 Pathway Signaling (website)
  • Regulation of p120-catenin tumor supressor activities (website)
  • Regulation of Tumor and Metastatic Growth by Hypoxia and CTGF (website)
  • Resequencing and Functional Studies to Identify Causal Gene Variants of Lymphoma (website)
  • Resistance and Relapse in Chronic Myeloid Leukemia (website)
  • Retrotransposon instability in glioblastoma multiforme (website)
  • Riluzole Prodrugs for Melanoma and ALS (website)
  • Risk of Non-Hodgkin’s Lymphoma in Relation to Tricyclic Antidepressant Use (website)
  • RNA Therapeutics for Pancreatic Cancer (website)
  • Role of a pro-apoptotic Bcl-2 protein in the survival and death of leukemia cells (website)
  • Role of Age in Liver Cancer (website)
  • Role of ASXL1 mutations in myeloid malignancies (website)
  • Role of endothelial cancer cell engulfment during metastatic brain invasion (website)
  • Role of epigenetic regulators in pancreatic cancer (website)
  • Role of GSK-3 isoforms in Pancreatic Cancer (website)
  • Role of Hypoxia-Induced miR-210 in Tumor Metabolism (website)
  • Role of IGF-IR tyrosine kinase in NPM-ALK-expressing T-cell lymphoma (website)
  • Role of miR-124a in HTLV-I oncogenesis (website)
  • Role of p190RhoGEF (Rgnef) in cell motility and tumor progression (website)
  • Role of p27 in chronic myeloid leukemia and its potential as a therapeutic target (website)
  • Role of PKC iota in metaplasia and initiation of pancreatic cancer (website)
  • Role of Reactive Oxygen Species in B Lymphoma Fate (website)
  • Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumor (website)
  • Role of Shp2 in FLT3-ITD-Induced Leukemogenesis (website)
  • Role of the Fractalkine Signaling in EOC (website)
  • Role of the mitochondrial RNA polymerase POLRMT in MYC function (website)
  • Role of the Perivascular Microenvironment in Primary and Metastatic Brain Tumors (website)
  • Roles of SIRT1 in normal hematopoietic and leukemic stem cells (website)
  • RON Receptor in Pancreatic Cancer Biology and Therapy (website)
  • RRSS Evaluate Completeness Liver Cancer Reporting Under New Clinical Guidelines (website)
  • RRSS Improving SES Data: Linkage w State Vital Records, Birth Certificate Data (website)
  • SATB1-dependent epigenetic regulation of leukemia initiating cells (website)
  • See, Reach, Treat Tumor-Optimized Transarterial Chemoembolization Drug Delivery (website)
  • Serum exosome biomarkers for evaluation of glioma drug response (website)
  • Serum glycoprotein markers of cancer using an ion mobility/mass spec approach (website)
  • Serum IgE and Risk of Pancreatic Cancer (website)
  • Serum microRNA signature as prospective HCC biomarker in HBV patients (website)
  • Sideport Needle Array Technologies for Prioritizing Drugs for Cancer Patients (website)
  • Small molecular weight eNOS inhibitors for the treatment of pancreatic cancer (website)
  • Specific Adoptive Immunotherapy of Leukemia (website)
  • Stem Cells And The Origins of Barrett’s Esophagus (website)
  • Stem Cells, Differentiation and Therapeutic Resistance in AML (website)
  • Stopping the Start: Understanding PanIN Initiation and Progression (website)
  • Structure/Function of AF9 and MLL-AF9 (website)
  • Survivorship: Mentoring and Bridging Primary Care and Oncology (website)
  • Synergistic chemo-siRNA combination therapy (website)
  • Targeted Delivery of a Novel Synthetic Curcumin Analog, EF24 to Glioblastoma and (website)
  • Targeted Development of Platinum Drugs (website)
  • Targeted Improvement in Stem Cell Therapy for Leukemia and Bone Marrow Failure Sy (website)
  • Targeted Photoactivable Nanocells: Image-based Drug Delivery and Dosimetry in GBM (website)
  • Targeted Radiotherapy with 90Y-BC8 Monclonal Antibody, Fludarabine and TBI Follow (website)
  • Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma (website)
  • Targeted therapy of pancreatic cancer with in vivo radionuclide generator (website)
  • Targeted Treatment of Recurrent Small Cell Lung Cancer with Anti-AbnV2 Antibodies (website)
  • Targeting Akt Activation in CLL (website)
  • Targeting AKT signaling in AML (website)
  • Targeting Alloreactivity for Leukemia Eradication (website)
  • Targeting AML-stromal interactions (website)
  • Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia (website)
  • Targeting mitochondrial protein synthesis with tigecycline for the treatment of l (website)
  • Targeting Neuropilin 2 with Semaphorin 3F during Pancreatic Carcinoma Progression (website)
  • Targeting Src Signaling Pathways to Promote Cell Cycle Arrest in Ovarian Cancer (website)
  • Targeting SYK Tyrosine Kinase to Overcome Radiation Resistance in ALL (website)
  • Targeting the heat shock response for the therapy of DLBCL (website)
  • Targeting vFLIP for the treatment of KSHV-associated malignancies (website)
  • Tas::75 0849::tas sbir topic 255 phase ii development of anticancer agents (website)
  • Tas::75 0849::tas sbir topic 292 phase i development of molecular pharmacodynami (website)
  • Tas::75 0849::tas sbir topic 307 phase i novel imaging agents to expand the clin (website)
  • Tas::75 0849::tas topic 255 development of a targeted therapy for acute myeloid (website)
  • Tas::75 0849::tas topic 255 development of gb13 as a novel glioblastoma therapy (website)
  • Tas::75 0849::tas topic 255 selective and potent inhibitors of tumor specific gl (website)
  • Temporally controlled oncogene expression in a novel pancreatic cancer model (website)
  • The ALK receptor tyrosine kinase as a therapeutic target in neuroblastoma (website)
  • The genetics of ocular melanoma (website)
  • The glucocorticoid receptor as signal integrator: studying ALL drug resistance (website)
  • The High Cost of Risk Reduction: Addressing Sexual Dysfunction after Oophorectomy (website)
  • The role of a novel BRCA1 associated complex in DNA damage response and tumor sup (website)
  • The Role of AGR2 in a Murine Model of Pancreatic Adenocarcinoma (website)
  • The Role of ATM in Suppression of Lymphomas (website)
  • The Role of BRAF Mutation in Thyroid Cancer Invasion (website)
  • The role of c-Maf in Stem cells in Leukemia (website)
  • The Role of Dendritic Cells in Pancreatic Tumorigenesis (website)
  • The Role of Heme Metabolic Pathways in T Cell Development and T Cell Lymphomagene (website)
  • The Role of HMGB1 in the Pathogenesis of Mesothelioma (website)
  • The role of microRNAs in leukemic initiation and maintenance (website)
  • The role of miRNA15a and 16-1 in Multiple Myeloma (website)
  • The role of Nkx2-1 in lung adenocarcinoma (website)
  • The Role of p21-Activated Kinases in Malignant Mesothelioma (website)
  • The Role of the PI3K-AKT Pathway in Melanoma Brain Metastasis (website)
  • The Significance of Isocitrate Dehydrogenase Mutations in Gliomas (website)
  • The vascular niche in glioma propagation and resistance to therapy (website)
  • Therapeutic delivery of anti-miR oligos to hepatocellular cancer (website)
  • Therapeutic Opportunities for Pediatric Astrocytoma (website)
  • TOR signaling and autophagy in obesity-promoted liver tumorigenesis (website)
  • Toward an understanding of CLL progression (website)
  • Training Program in Pediatric Cancer Epidemiology and Control (website)
  • Transcriptional regulation of gliomagenesis (website)
  • Transglutaminase Modulated Tumor-Stroma Interaction in Pancreatic Cancer (website)
  • Translational Control by eIF3f in Pancreatic Cancer (website)
  • Translational Regulation of the Inflammatory Breast Cancer Stem Cell (website)
  • Transplantation of Purified Hematopoietic Cell Populations Acroos Allogenic Barie (website)
  • Transponson-based screens for genes involved in acute lymphoblastic Leukemia (website)
  • Tri-modal Polymeric Micelles for ‘See & Treat’ Applications in Surgical Oncology (website)
  • Trisomy 8 in hematopoiesis and myeloid leukemia (website)
  • Tumor induced senescent and suppressor T cells – a novel mechanism of immune evas (website)
  • Tumor microenvironments determing migration, dissemination and dormancy (website)
  • Tumor Suppressor Role of ARID1A (website)
  • Tumorigenic Role of the CUL4A Ubiquitin Ligase (website)
  • TWIST1 as a target for inhibition of glioma invasion (website)
  • Tyrosine kinase oncogenes in acute myeloid leukemias (website)
  • Ultrasound enhanced penetration for treatment of pancreatic cancer (website)
  • Understanding the origin and pathogenesis of epithelial ovarian cancer (website)
  • Urinary biomarkers of renal cell carcinomas (website)
  • Use and Comparative Effectiveness of Innovative Therapies for Hepatocellular Carc (website)
  • Use of nanogels to target delivery of siRNA to cancer cells in mice (website)
  • Using Ketogenic Diets to Enhance Radio-Chemo-Therapy Response: A Phase I Trial (website)
  • Utrasensitive bioassays using palladium catalyzed chemical amplification (website)
  • Vaccine-Dac/Bev Combinatorial Therapy in Ovarian Cancer (website)
  • Validating a novel biomarker of clinical progression and survival in CLL (website)
  • Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci (website)
  • Validation of an Antibody Test for Early Diagnosis of Ovarian Cancer (website)
  • Validation of copy number changes by MLPA as predictors of relapse in Wilms tumor (website)
  • Validation of microRNAs as therapeutic targets in hematological malignancies (website)
  • Virotherapy for pancreatic cancer with wildtype and armed Myxoma viruses (website)
  • Virus-gene interactions during hepatic carcinogenesis (website)
  • Virus-Targeted Therapy for Malignancies (website)

2010

  • A bifunctional nanomedicine for both specific imaging and targeting therapy of an (website)
  • A High Throughput Protein Complementation Assay for Inhibitors of NEMO-K13 Intera (website)
  • A Model for Preclinical Biomarker Discovery in Pancreatic Ductal Adenocarcinoma (website)
  • A Multidisciplinary and Translational Approach to Hepatobiliary Malignancy (website)
  • A New Method for Improved Targeting in Image-guided Abdominal Interventions (website)
  • A Novel Nanocoaxial Biosensor for Detection of Cancer Biomarkers (website)
  • A Novel ROS Controlling Kinase (website)
  • A Novel sequencing-based approach to discovering rare genetic factors for ALL (website)
  • A Phase I/II Trial of Eltrombopag in Elderly Acute Myeloid Leukemia Patients (website)
  • A20 Promotes Glioma Stem Cell Mediated Tumorigenesis (website)
  • Abrogating human CD59 activity for antibody-based cancer therapy (website)
  • Academic-Industrial Partnership to Develop & Test Esophageal Cancer Imaging Tools (website)
  • Adoptive T-Cell Therapy for Acute Leukemia (website)
  • Adoptive Transfer of AlloCTL for Immunotherapy of Recurrent Gliomas (website)
  • Akt-EphA2 Crosstalk in Glioma Invasion (website)
  • An integrated systems biology approach for ovarian cancer biomarker discovery (website)
  • An RNAi Screen in Drosophila Cells for Kinases Involved in TOR Regulation (website)
  • Analysis of a novel regulator of hepatocellular carcinoma (website)
  • Analysis of LC-MS data to identify peptide and glycan biomarkers for hepatocellul (website)
  • Analysis of the leukemic stem cell niche in chronic myeloid leukemia (website)
  • Antibody-CpG conjugates for the treatment of B cell lymphoma (website)
  • Apical-basal polarity signaling in glioblastoma (website)
  • Aspects of MUC13 Mucin in Cancer (website)
  • Assessing pancreatic cancer susceptibility to ceramide-mediated cell death (website)
  • Assessment of Inherited Colon Cancer Prediction Models in Diverse Populations (website)
  • Autoregressive Joinpoint Analysis of Cancer Trend Data (website)
  • AXII in the Multiple Myeloma Bone Microenvironment (website)
  • Bayesian Risk Modeling of Racial-spatial Interactions Among Childhood Cancer Hist (website)
  • BCR/ABL-PI-3k-ROS pathway induce genomic instability ….  (website)
  • Berberine downregulates MDM2 by interaction with DAXX in cancer cells (website)
  • BETR Therapy for Herpesvirus-Associated Tumors (website)
  • Biomarkers of Disease Progression in CLL (website)
  • Biosensor design for detection and analysis of complex signal patterns in cancer (website)
  • Bone Marrow Transplantation for Hematologic Malignancies using Novel Radioimmunot (website)
  • Brain Endothelial TNF-R1 Can Function to Inhibit Angiogenesis (website)
  • Breast and Ovary Cancer Clinical Validation Center (website)
  • CD147 as a Novel Target in Head and Neck Cancer (website)
  • CD44 Antagonists in Targeted and Combinational Therapy for Glioblastoma (website)
  • Cell Cycle Regulation and Adult T Cell Leukemia (website)
  • Cellular and Molecular Requirements for Medulloblastoma Tumorigenesis (website)
  • Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa (website)
  • Characterizing the Role of NF-kB in Promoting Glioma Tumorigenicity (website)
  • CITP-Based Selective Tissue Proteome Enrichment (website)
  • Clonogenic Characterization of Myeloma Progenitor Cells (website)
  • Columbia-South Africa Training Program for Research on HIV-associated Malignanci (website)
  • Combination therapy to inhibit neuroblastoma growth (website)
  • Combined inhibition of CXCR4 and FLT3-ITD signaling in acute myeloid leukemia (website)
  • Computer-Aided Detection of Urinary Tract Cancer on MDCT Urography (website)
  • Controlling Esophageal Cancer in the US.: A Colloraborative Modeling Project (website)
  • Coordinately regulated alternative splicing in DNA damage and cancer (website)
  • Copy number variations (CNVs) in neuroblastoma (website)
  • C-reactive protein promotes myeloma cell-mediated bone destruction (website)
  • CRLF2 signaling in B-cell acute lymphoblastic leukemia (website)
  • Cx43 phosphorylation modulates Kras mediated pancreas cancer progression (website)
  • Decoding the MST1 and MST2 kinases in cellular physiology and tumor suppression (website)
  • Defining genetic pathways of plasma-cell neoplasia (website)
  • Defining lineage-specific determinants of K-Ras « addiction » in human cancers (website)
  • Dendritic Cell/Leukemia Fusions and PD-1 Blockade for AML (website)
  • Detection of Pre-Invasive Pancreatic Cysts Using Protein and Glycan Biomarkers (website)
  • Developing diagnostic and therapeutic stem cells for cancer therapy (website)
  • Developing Research Capacity for AIDS Malignancy in Kenya (website)
  • Development & Dissemination of Education in Pediatric Palliative Care (website)
  • Development and validation of an imaging-based biomarker of therapeutic efficacy (website)
  • Development and validation of prognostic model for gastric cancer (website)
  • Development of a multimarker urine-based test for early diagnosis and screening o (website)
  • Development of a Novel Strategy to Prevent Experimental GVHD (website)
  • Development of an interferon-alpha-veltuzumab conjugate for CD20-targeted therapy (website)
  • Development of Inhibitors of the Leukemia Fusion Protein CBFbeta-SMMHC (website)
  • Development of Microscopic Spectral Markers for Diagnosis of Pancreatic Lesions (website)
  • Device to Improve Treatment of Colorectal CA using O2 Dependent Phosphorescence (website)
  • DICER1 and the Pleuropulmonary Blastoma Family Cancer Syndrome (website)
  • Differential Delivery of Follow-up Care and Survivorship Among Latinos Using Medi (website)
  • Diffuse Optical Monitoring of Head and Neck Tumor Therapy (website)
  • Discover and Engineer New Histone Deacetylase Inhibitors as Anticancer Agents (website)
  • Discovering chemical tools for acute myelogenous leukemia (website)
  • Disruption of Cellular Messenger RNA Processing Events by the Kaposi’s Sarcoma-As (website)
  • Dissecting sarcoma complexity via innovative microRNA and informatics approaches (website)
  • Dissecting the mechanisms of immune tolerance within the pancreatic tumor’s micro (website)
  • Dissecting the roles of stellate cells in pancreas cancer progression (website)
  • DNA methylation-based assays for detecting disease spread in rhabdomyosarcoma (website)
  • Drug Resistant Pathways in Relapsed Acute Lymphoblastic Leukemia (ALL) (website)
  • Dual Targeting of DNA Repair and p53 pathways for treatment of brain cancer (website)
  • Dynamic multimodal imaging of tumor hypoxia and vascular profiles in glioblastoma (website)
  • E6 Oncoprotein Based Rapid Test for Anal Neoplasia (website)
  • EBNA1 Functions Required in Burkitt’s Lymphomas and Other Immortalized B-Cells (website)
  • EGFR-Targeted Nanoemulsions for Imaging and Therapy of Ovarian Cancer (website)
  • EKLF (KLF1): A Potential Tumor Suppressor? (website)
  • Energy balance and nutrigenetic analysis of non-Hodgkin lymphoma (website)
  • Engineered lymphocytes for the treatment of hepatocellular carcinoma (website)
  • Engineered tumor-specific T cells Resist Hypoxic-Tumor Immunosuppressive Attacks (website)
  • Engineering tyrosine kinase-activated caspases for selective cancer cell killing (website)
  • Enhancing antitumor immunity with anti-PD-1 antibody in follicular lymphoma (website)
  • Enhancing the Biomedical Computing Platform for Pancreatic Cancer Research (website)
  • Enhancing tumor-targeted antibody therapy with a second NK activating antibody (website)
  • Enzyme-instructed self-assembly for anticancer nanomedicine (website)
  • Epidemiologic Study of Hepatocellular Carcinoma in the US (website)
  • Epidemiology of Ovarian Cancer in African-American Women (website)
  • Epidermal growth factor regulation of miR-125a promotes invasive ovarian cancer (website)
  • ErbB Receptor Signaling in DEN-induced Murine Hepatocarcinogenesis (website)
  • Esophageal Adenocarcinoma Policy Model: Trends, Risk Factors and Screening (website)
  • Evaluation of In Vivo Optical Imaging in Pancreatic and Ovarian Cancer Patients (website)
  • EWS/FLI and its targets in Ewing’s sarcoma (website)
  • Exercise-mediated protection against brain metastases (website)
  • Exploiting altered glucose utilization in Bcr-Abl+ Leukemia (website)
  • Exploiting Biological Networks to Improve Clinical Treatment of Ovarian Cancer (website)
  • ‘Exvading’ Invasive Pediatric Brain Tumors (website)
  • Fiber bundle-based divided-pupil confocal endoscope (website)
  • Fluorophore-Conjugated Antibodies for Imaging and Resection of GI Tumors (website)
  • Fractionated, Dual-targeted radioimmunotherapy for follicular lymphoma (website)
  • Function and Regulation Mechanisms of Polo-like Kinase 3 in Pancreatic Cancer (website)
  • Functional Characterization of Lung Adenocarcinoma Progression and Metastasis (website)
  • Functional Validation of Pancreatic Cancer Progression Biomarker (website)
  • Fusion gene mutations as biomarkers of pancreatic cancer lymph node metastases (website)
  • Gastric Cancer Prevention: Evaluating U.S. Risk Factor Trends and New Technology (website)
  • Gene Expression of Neuroblastoma and Normal Cells in Bone Marrow Predicts Outcome (website)
  • Generation and utility of NADPH oxidase inhibitors (website)
  • Genetic and Proteomic Analysis of Epstein-Barr Virus LMP1 Activation of NF-kB (website)
  • Genetic Approaches to Pancreatic Cancer Progression (website)
  • Genetic Epidemiology of Ovarian and Prostate Cancer (website)
  • Genetic Predictors of AML Treatment Response (website)
  • Genome Wide Admixture Scan for Multiple Myeloma in African Americans (website)
  • Genomic Approaches to Defining Inherited Basis of Childhood Cancer (website)
  • Gli Activity in the Pancreas: Inflammation, Tissue Repair and Cancer (website)
  • GLI1 and Cancer Stem Cells in Ewing Sarcoma (website)
  • Glucocorticoids in Lymphoblastic Leukemia (website)
  • Hedgehog signaling in head and neck cancer stem cells, and its role in resistance (website)
  • HES1 mediates cell-specific consequences of Notch signaling in ALL (website)
  • High Definition Clonal Analyses of Archival Pancreatic Adenocarcinoma Samples (website)
  • Histone methyltransferase G9a in liver pathophysiology and carcinogenesis (website)
  • HTLV I Tax1 protein chemosensitization of p53 mutant tumors (website)
  • Hyperspectral Microendscopy to Monitor VEGF During Pancreatic Cancer Therapy (website)
  • Identifying a Hypoxia Inducible Factor target profile in Renal Cell Carcinoma tum (website)
  • Identifying antigens bound by novel scFvs targeting all subtypes of mesothelioma (website)
  • Identifying Malignant Cell Signaling from Protein Interactions an Polyomic Data (website)
  • Identifying Ovarian Cancer Susceptibility Alleles using Genome-Wide Scan Data (website)
  • IHC Test for BRCA1 Hereditary Ovarian Cancer (website)
  • IL12 Gene Therapy For Enhancing Therapeutic Efficacy of Bleomycin Against Oral Tu (website)
  • Immunologic targets in Myeloid Leukemia (website)
  • Immunosuppressive Network of Human Hepatocellular Carcinoma (website)
  • Impact of Vaccination against GM2, GD2 and GD3 on Disease Free Survival in Resect (website)
  • Improving Delivery of Molecularly-Targeted Therapy to Invasive Glioma Cells (website)
  • Improving T-cell therapies for neuroblastoma (website)
  • Improving the Efficacy of Cisplatin-Based Cancer Chemotherapy (website)
  • Inactivation of Hdac3 in the cause, prevention, and treatment of HCC (website)
  • Inflammation Variants and Risk of Hepatocellular Carcinoma in HBV Patients (website)
  • Inhibition of B-Catenin Signaling for Treatment of Hepatocellular Carcinoma (website)
  • Inhibition of interleukin-6 production for the treatment of multiple myeloma (website)
  • Inhibitor of Adrenal Steroid Synthesis for Cancer Treatment (website)
  • Initiation, persistence, and progression of hepatocellular carcinoma (website)
  • Innovative Delivery Strategy for CaSm Gene Therapy in Pancreatic Cancer (website)
  • Integrated Genomics Profile of Relapsed Childhood Acute Lymphoblastic Leukemia (website)
  • Integrated Imaging and Photothermal Ablation of Pancreatic Cancer Resection Margi (website)
  • Integrin-targeted siRNA delivery for therapeutic gene silencing in blood cancers (website)
  • Interferon Responses in Myeloid Leukemia (website)
  • Intermittent hypoxia on the progression of neuroblastoma (website)
  • International Case Control Study of Malignant Glioma (website)
  • Investigating the functions of the miR-17~92 family of oncogenic microRNA cluster (website)
  • Investigating the Needs of Childhood Cancer Survivors: The UnReported Experience (website)
  • Investigations on the role of the CDK8 oncogene in colon cancer (website)
  • IR signaling through PP6, a potential molecular target for radiosensitization (website)
  • K-Rta as a Novel SUMO and Epigenetic Regulator (website)
  • Label free imaging of blood smears and tissue biopsies (website)
  • Lentiviral-MGMT gene transfer into hematopoietic stem cells (website)
  • Leukemia Stem Cell Properties and Relevance During Therapy for AML (website)
  • Long-term Treatment Related CNS Injury in Survivors of Childhood Cancer (website)
  • Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk Reduction (website)
  • Lysophospholipids in Radiation Induced Signal Transduction in Malignant Gliomas (website)
  • Magnetic Nanoparticles and Quantum Dots for Diagnosis of Early Stage Ovarian Canc (website)
  • Magnetoresistive Sensor Platform for Parallel Cancer Marker Detection (website)
  • Mammalian H3K4 Methylases, Chromosomal Translocations and Human Leukemia (website)
  • Mechanism of BCL6-dependent stem cell maintenance in B cell lineage leukemia (website)
  • Mechanism of DLC1-mediated tumor suppression (website)
  • Mechanism of Merlin-mediated contact inhibition and tumor suppression (website)
  • Mechanisms of MEK/ERK growth arrest signaling (website)
  • Mechanisms of Overexpressed TrkB in Inducing Pancreatic Cancer Metastasis (website)
  • Mechanisms of T cell leukemia induction and maintenance (website)
  • Mechanisms regulating epithelial mesenchymal transition in development and glioma (website)
  • Medulloblastoma and Metastases (website)
  • Metabolomic and Integromic Approaches to Identify Fingerprints for Early Detectio (website)
  • Microgranular Curcumin Biomarker Trial in Head and Neck Squamous Cell Carcinoma (website)
  • microRNA-155 and Lymphoma (website)
  • MIM regulates Shh target gene expression in tumors (website)
  • Mining B-catenin/BCL9 transcriptional complex for Multiple Myeloma therapeutics (website)
  • Mitochondrial Apoptotic Sensitivity in Predicting Acute Myeloid Leukemia Response (website)
  • Mitochondrial Dysfunction and Chemoresistance in Malignant Gliomas (website)
  • Mitochondrial genome analysis of epithelial serous ovarian carcinoma (website)
  • MLL in Hematopoiesis and Leukemia in the Zebrafish Model (website)
  • Modifiers of Notch stability and their role in cancer (website)
  • Modulation of liver cancer by PPARbeta/delta (website)
  • Modulation of Resistance to antiangiogenic therapy: A clinical trial with correla (website)
  • Modulation of RGS proteins and Ovarian Cancer Chemoresistance (website)
  • Molecular and Cellular Characterization of Prognostic Immune Response in Childhood (website)
  • Molecular Combinatorial Therapy of Glioblastoma Multiforme (website)
  • Molecular Epidemiology of B cell Activation, DNA Repair & HIV-Associated Lymphoma (website)
  • Molecular etiology of cervicovaginal adenosis by in utero hormone exposure (website)
  • Molecular interactions and restoration strategies of PTEN and p53 in gliomas (website)
  • Molecular Mechanisms for the Assembly and Regulation of the MLL1 Core Complex (website)
  • Molecular Pathogenesis and Therapy of ET and PMF (website)
  • Molecular pathogenesis of MLL-AF4 leukemias (website)
  • Molecular Risk Assessment in Hereditary Melanoma (website)
  • Molecular Targeting of Diffuse Large B-cell Lymphoma (website)
  • Molecular Targeting Strategies in HNSCC (website)
  • Monoclonal Antibody to FGF2 for Treatment of Hepatocellular Carcinoma and Other C (website)
  • MRI for In Vivo Quantification of Yttrium-90 Microsphere Biodistribution (website)
  • MRI of Iron-labeled Microsphere Biodistribution for Radioembolization Dosimetry (website)
  • mTOR Inhibition as a Therapeutic Strategy for Acute Myeloid Leukemia (website)
  • Multifunctional Nanotherapeutics for Cancer Treatment and Imaging (website)
  • Multifunctional roles of homeobox gene DLX4 in ovarian cancer (website)
  • Multiple kinase target inhibition with EMND-2076 in multiple myeloma (website)
  • Multiple Myeloma and Cancer Therapies via Largazole Analogs (website)
  • Multiple Tumor Antigen-loaded DC Vaccine for Hepatocellular Cancer (website)
  • Multipotent mesenchymal stem cell-like cells in pancreatic tumorigenesis (website)
  • Myeloma stem cell and cancer testis antigens (website)
  • Myxoma Virus (MV) Oncolysis for treating human cancer (website)
  • Nanoconjugate based on polymalic acid for brain tumor treatment (website)
  • Nanoparticle-Directed Photothermal Ablation of Primary Brain Tumors guided by Mag (website)
  • Nanoscale analysis of proteomic response to novel targeted therapies for lymphoma (website)
  • Nanoscale Metal-organic Frameworks for Imaging and Therapy of Pancreatic Cancer (website)
  • NEK2 Over-expression Causes Drug Resistance in Myeloma (website)
  • NK cell-myeloid cell crosstalk in patients with cancer (website)
  • NMR Structural Studies of Ubiquitin Receptor Protein Complexes (website)
  • Non-Hodgkin lymphoma in women: reproductive, hormonal and genetic factors (website)
  • Notch in Neuroblastoma (website)
  • Novel Approaches for Structural Determination of Cancer Stem Cell Glycans (website)
  • Novel approaches to enhance tumor cell cytotoxicity of alkylating agents (website)
  • Novel Biologically Targeted Therapy Against the Mer and Axl Receptor Tyrosine Kin (website)
  • Novel Biomarkers in Ovarian Cancer (website)
  • Novel CTD inhibitors with synthetic lethality to oncogenic Ras for cancer therapy (website)
  • Novel Heparanase Inhibitors for Cancer Therapy (website)
  • Novel Molecular Mechanism of Glioma Pathogenesis (website)
  • Novel selective small-molecule inhibitors of Mcl-1 protein (website)
  • Novel targeted therapies for BRCA-associated cancer (website)
  • Nrf2 a new therapeutic target for human pancreatic ductal adenocarcinoma (website)
  • Obesity in ovarian cancer prognosis (website)
  • On the trail to pancreas cancer-selective tumor cell death (apoptosis) (website)
  • Oncogene cooperation in glioma genesis (website)
  • Oncogene Mutation Profiling in Uveal Melanoma (website)
  • Optimizing Induction Conditions for Immunotherapeutic CTL (website)
  • Oral Cancer Screening via Spectral Cytopathology (website)
  • OSU-03012 therapy for glioblastoma (website)
  • Ovarian cancer diagnosis by monitoring immune cell bound MUC16 (CA125) (website)
  • p21-Activated Kinases as New Therapeutic Targets in Neurofibromatosis Type 1 (website)
  • p53 Family in Gastric Cancer Development (website)
  • P53-dependent GSTP1 Gene Regulation and Glioma Drug Resistance (website)
  • p53-independent function of Mdmx in tumorigenesis (website)
  • PAARK4Kids-Pharmacogenomics of Anticancer Agents Research in Children (website)
  • Pancreatic Stem Cells and Cancer (website)
  • Papillary thyroid cancer and tumor-associated macrophages (website)
  • Patterns of Care and Outcomes for Glioblastoma Patients (website)
  • Pax8-PPARgamma regulation of transcription and metabolism in thyroid cancer (website)
  • Pediatric Cancer, Family Conflict and Child Adjustment (website)
  • Peptide-Based Vaccine Therapy for Childhood Malignant Gliomas (website)
  • Peptide-directed protocells and virus-like particles-new nanoparticle platforms f (website)
  • Phospho-valproic acid for pancreatic cancer prevention (website)
  • Photoacoustic endoscopy of Barretts esophagus (website)
  • Polyomavirus-Associated Human Cancers (website)
  • Pooling and expansion of Chronic Lymphocytic Leukemia GWA data (website)
  • Preclinical Development of JS-K, a Novel NO-Generating Prodrug for Cancer (website)
  • Preclinical Evaluation of ERBB Family Members as Therapeutic Targets in Osteosarc (website)
  • Preclinical platform for theranostic nanoparticles in pancreatic cancer (website)
  • Predicting outcome of experimental therapy in lymphomas by 31P & 1H MRS (website)
  • Prediction Model: Breast Cancer in Women Irradiated for a Pediatric Malignancy (website)
  • Prediction of Pathologic Complete Response by Gene Expression Profiling in Esopha (website)
  • Predictors of myelodysplastic syndrome in Minnesota (website)
  • Probiotic Metabolism of Rice Bran Phytochemicals for Chemoprevention (website)
  • Prognostic markers in metastatic melanoma (website)
  • Prospective studies of cancer etiology and prevention in Shanghai and Singapore (website)
  • Protein Kinase D in oncogenic oxidative stress signaling (website)
  • Proteomic and Functional Studies of Mitochondrial Proteins Involved in ROS Metabo (website)
  • Proteomic, Genetic & Longitudinal Pathways to Ovarian Cancer Biomarker Discovery (website)
  • Quality of Life in Adolescent and Young Adult Testicular Cancer Survivors (website)
  • Quantitative glycoproteomics for pancreatic cancer studies (website)
  • Queens Cancer Center Minority-Based Community Clincal Oncology Program (website)
  • Radioimmunotherapy for Multiple Myeloma (website)
  • Rare Protein Detection on Cell Surfaces: Ultrasensitive Detection of B-Cell Chron (website)
  • Regulation of hepatic NKT cells by CDld+ liver cells (website)
  • Regulation of HTLV-1 and cellular gene transcription by the viral protein HBZ (website)
  • Regulation of microRNA-16 by benzyl isothiocyanate in pancreatic cancer (website)
  • Retinoid Based Treatment Approaches to Target the Myeloma Stem Cell (website)
  • RhoB in cancer pathogenesis and as a target in combinatorial therapy (website)
  • Risk of Leukemia after Protracted Exposures to Low Doses of Ionizing Radiation (website)
  • RNA from Brush Cytology to Detect Squamous Cell Carcinoma (website)
  • RNA Nanotechnology in Cancer Therapy (website)
  • Role of adhesin-receptor interaction in H. pylori-induced gastric carcinogenesis (website)
  • Role of Autotaxin in HCV-associated Hepatocellular Carcinoma (website)
  • Role of Dietary Zinc Transporter ZIP4 in Pancreatic Cancer (website)
  • Role of DOK family proteins in lung tumor suppression (website)
  • Role of Fibroblasts, Myeloid Cells and Matrix in PDAC (website)
  • Role of gammaherpesvirus lytic replication-associated genes in the establishment (website)
  • Role of Genetic Susceptibility in Therapy-related Subsequent Malignancies (website)
  • Role of HIV-1 Tat in the activation of HERV-K and development of HIV-1-lymphoma (website)
  • Role of IDH1 and IDH2 Mutations in Glioma Cellular Biology and Pathogenesis (website)
  • Role of NF-kB in hematopoietic stem cells and leukemia-initiating cell formation (website)
  • Role of rac and reactive oxygen species in kaposi’s sarcoma viral  oncogenesis (website)
  • Role of replication stress during MYC-dependent lymphomagenesis (website)
  • Role of Setbp1 in leukemic stem cell self-renewal (website)
  • Role of Sonic Hedgehog Signaling Pathway in Diffuse Large B-Cell Lymphoma (website)
  • Role of the BMP SMADs in Oncogenesis (website)
  • Role of the Bone Marrow Microenvironment in the Development of Multiple Myeloma (website)
  • Role of Tumor Microenvironment in Ovarian Cancer Progression (website)
  • Roles of C19ORF5 and LRPPRC in Autophagy and Tumor Suppression (website)
  • Rpl22 as Biomarker of Prognosis and Therapeutic Response in T-ALL (website)
  • Screening of inhibitors of SIRT1 and SIRT2 for the prevention of neuroblastoma (website)
  • Selective sensitization of pancreatic tumor cells to chemotherapy (website)
  • Serological Markers Of Periodontal Disease And Pancreatic Cancer Risk (website)
  • Sex Chromosomes and Gender Disparity in HBV-Related Hepatocellular Carcinoma (website)
  • SFRP2 and NFAT are therapeutic targets in angiosarcoma (website)
  • Shared Genomic Segment Analysis for Localizing Multiple Myeloma Genes (website)
  • SIAH2-Dependent Proteolysis in Cell Migration, Tumor Growth and Cancer Metastasis (website)
  • Signal Transduction Pathways in CD30-positive Lymphomas (website)
  • Signaling in the ovarian cancer metastatic microenvironment (website)
  • Simultaneous Tc-99m-MDP/I-123-MIBG Imaging of Neuroblastoma Using SPECT-CT (website)
  • Small Molecule Inhibitors for the Oncogenic Protein Tyrosine Phosphatase SHP2 (website)
  • Smart Packaging: A Novel Technique for Localized Drug Delivery for Ovarian Cancer (website)
  • Sociocultural Factors and BRCA Genetic Counseling for Diverse Latinas (website)
  • Stat3 Downstream Genes as Lung Adenocarcinoma Biomarkers (website)
  • Statins & Lymphoid Malignancy Risk in a Large Multi-Site Population-Based Cohort (website)
  • Sunitinib Modulation of Cancer Immunotherapy (website)
  • Synstatin Therapy for Multiple Myeloma (website)
  • Targeting aberrant epigenetics by nanomedicine (website)
  • Targeting apoptosis via chemical design of Bcl-2 antagonists (website)
  • Targeting ATDC with PARP inhibitors in pancreatic cancer (website)
  • Targeting Brain Tumor Stem Cells Through Novel Therapeutic Combinations (website)
  • Targeting Cdc42 in leukemia stem cells (website)
  • Targeting c-Src in Head and Neck Cancer (website)
  • Targeting epigenomic signatures in non-hodgkin lymphoma for novel therapeutics (website)
  • Targeting Fas Inhibitors in Cancer Therapy (website)
  • Targeting Histone Deacetylases with Small Moleule Inhibitors in Ovarian Cancer (website)
  • Targeting hypoxic bone marrow microenvironment in Acute Myeloid Leukemia (AML) (website)
  • Targeting invasion and DNA DSB repair in glioma with a multi-pronged approach. (website)
  • Targeting lipid metabolic and signaling enzyme in ovarian cancer (website)
  • Targeting myeloid-derived suppressor cells for gastric cancer prevention (website)
  • Targeting Negative Regulatory Pathways for Immunotherapy of B-Cell Lymphomas (website)
  • Targeting Pancreatic Cancer Using Peptide Chemistry: From Bench to Bedside (website)
  • Targeting PML for leukemia therapy (website)
  • Targeting PML for therapy in leukemia-initiating cells (website) 2012
  • Targeting Proteasome Inhibitor-mediated Resistance in Myeloma (website)
  • Targeting Ras-Ral GEF-Ral Effector Signaling for Pancreatic Cancer Treatment (website)
  • Targeting Somatic Homologous Recombination in Solid Tumors (website)
  • Targeting SYK Kinase in B-Lineage ALL with CD19-Specific C-61 Nanoparticles (website)
  • Targeting the Mullerian Inhibiting Substance pathway in gynecologic cancer (website)
  • Targeting the tumor matrix as anti-invasive and sensitizing strategy for glioma (website)
  • Targeting Tumor Hypoxia with Radiohalogenated Inhibitors of Carbonic Anhydrase IX (website)
  • T-cell Therapy for B-lineage Acute Lymphoblastic Leukemia (website)
  • Th1/Th17 Cell Differentiation in GVHD and GVL (website)
  • The adoptive transfer of gene-modified T cells as a cell therapy for lymphoma (website)
  • The ARF Tumor Suppressor (website)
  • The contribution of protein translation to tumorigenesis (website)
  • The Effect of Aflatoxin Regulation on Global Liver Cancer Risk (website)
  • The effect of p53 signaling on the metabolism and therapeutic response of glioma (website)
  • The Fibrosis-Lymphedema Continuum in Head and Neck Cancer (website)
  • The Meningioma Consortium: Genome-Wide Association Study (website)
  • The Mitochondrial Genome and Ovarian Cancer Risk (website)
  • The p110 alpha and delta isoforms of PI3 kinase in hematopoiesis and leukemia (website)
  • The role of chromatin regulation in normal and cancer stem cell self-renawal (website)
  • The Role of Cul4A in Genome Stability and Cancer Development (website)
  • The Role of CYP1B1 in the Recurrence of Head and Neck Cancer (website)
  • The role of DNA polymerase eta in DNA damage response and p53 activation (website)
  • The role of glutaminase 2, a novel p53 target gene in metabolism, in liver cancer (website)
  • The Role of glypican-1 in Pancreatic Cancer Development and Progression (website)
  • The role of Hedgehog in hematopoiesis and leukemogenesis (website)
  • The role of microRNA, mir-30d, in the initiation and progression of cancer (website)
  • The role of miR-155 in cell cycle regulation and tumorigenesis (website)
  • The Role of MMSET in DNA damage response and Chemoradioresistance (website)
  • The role of MTG8 in genomic stability and colorectal cancer development (website)
  • The role of NKG2D ligands in myeloid cell-NK cell crosstalk in cancer patients (website)
  • The Role of RECQL4 in Bone Development and Osteosarcoma (website)
  • The Role of the APC Tumor Suppressor Gene in Hematopoiesis and Leukemogenesis (website)
  • Theranostic Nano particles for Targeted Treatment of Pancreatic Cancer (website)
  • Therapeutic targeting of stratifin structure and function (website)
  • Thermally Targeted Cell Cycle Inhibitors for the Treatment of Pancreatic Cancer (website)
  • Thermally Targeted Delivery of c-Myc Inhibitory Polypeptides to Malignant Gliomas (website)
  • Toxicity and Efficacy of Gold Nanoparticle Photothermal Therapy in Cancer (website)
  • Transcription, Choice and the 3D Architecture of the Inactive X-Chromosome (website)
  • Translation of smart contrast agents for brain tumor characterization by MR (website)
  • Translational Research in GI Cancer (website)
  • Trauma and Growth in Pediatric Cancer (website)
  • TSC2 Localization and Function at the Peroxisome (website)
  • Tumor Targeted Nanobins for the Treatment of Metastatic Breast and Ovarian Cancer (website)
  • Tumor-cell-specific targets for combined hyperthermia and radiation effects (website)
  • Tumor-produced TNF alpha as an inducer of immune resistance and tumor survival (website)
  • Tyrosine kinase inhibitors for the treatment of childhood AML (website)
  • Tyrosine Kinase Signaling in Cancer Cell Metabolism (website)
  • Understanding Hemotopoietic Neoplasias using Humanized Mice (website)
  • Using mouse models to understand retinoblastoma initiation and progression (website)
  • Using Proton MRS to Predict Response of SAHA treatment in Glioblastoma (website)
  • Validating Cancer Risk Models: a Pilot Study to Evaluate Cost-efficient Methods (website)
  • Validation of microRNA Targets in Glioma (website)